Page last updated: 2024-10-26

valproic acid and Convulsive Generalized Seizure Disorder

valproic acid has been researched along with Convulsive Generalized Seizure Disorder in 243 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
" This paper presents an analysis of body weight data gathered during a randomized trial comparing valproate with carbamazepine in 260 children aged 4-15 years with newly-diagnosed epilepsy."9.08Weight gain with valproate or carbamazepine--a reappraisal. ( Easter, D; O'Bryan-Tear, CG; Verity, C, 1997)
"To review the time to withdrawal, remission and first seizure of phenytoin compared to valproate when used as monotherapy in people with partial onset seizures or generalised tonic-clonic seizures (with or without other generalised seizure types)."8.93Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review. ( Marson, AG; Nolan, SJ; Tudur Smith, C; Weston, J, 2016)
"To review the best evidence comparing phenytoin and valproate when used as monotherapy in individuals with partial onset seizures or generalised onset tonic-clonic seizures with or without other generalised seizure types."8.89Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. ( Marson, AG; Nolan, SJ; Pulman, J; Tudur Smith, C, 2013)
"To review the best evidence comparing phenytoin and valproate when used as monotherapy in subjects with partial onset seizures, or generalized onset tonic-clonic seizures with or without other generalized seizure types."8.81Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. ( Marson, AG; Tudur Smith, C; Williamson, PR, 2001)
"To evaluate the changes of epileptiform activity index (EAI) as a measure of the efficacy and tolerability of treatment with valproic acid (VA) in patients with newly-diagnosed generalized and focal epilepsy."7.96[Dynamics of epileptiform activity, efficacy and tolerability of valproic acid in adults and adolescents with newly-diagnosed epilepsy]. ( Karlov, VA; Kozhokaru, AB; Orlova, AS; Pushkar, TN; Vlasov, PN, 2020)
"To investigate the presence of insulin resistance in obese children with idiopathic epilepsy on valproic acid (VPA) monotherapy in comparison to obese otherwise healthy subjects."7.81Insulin resistance in patients on valproic acid: relation to adiponectin. ( Aly, RH; Amr, NH; Megahed, AA; Saad, WE, 2015)
"This study, in a meaningful number of exposed pregnancies, confirms a low risk for MCM with levetiracetam monotherapy use in pregnancy."7.79Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. ( Craig, J; Delanty, N; Hunt, SJ; Irwin, B; Liggan, B; Mawhinney, E; Morrison, PJ; Morrow, J; Parsons, L; Russell, A; Smithson, WH, 2013)
" MET test (PTZ at the dose of 70 mg/kg) acute seizures in Wistar rats, in comparison to valproic acid (VPA)."7.76Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats. ( Arcieri, S; Coppola, G; D'Aniello, A; Messana, T; Pascotto, A; Signoriello, G; Verrotti, A, 2010)
"A 28-year-old patient with a 5-year history of bipolar disorder developed signs of encephalopathy 2 weeks after the addition of valproic acid to his treatment regimen of doxepine, risperidone, and biperidene."7.70[Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy]. ( Rottach, KG; Schmauss, M; Weiss-Brummer, J; Wieland, U, 2000)
"Valproic acid induced coma is presented in an adult patient without a history of metabolic disease."7.68Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma. ( Colombo, JP; Straver, JS; van der Vijver, JC; van Woerkom, TC; Verbiest, HB, 1992)
"Epileptic myoclonus or myoclonic seizures can occur in idiopathic generalized epilepsy (IGE) and progressive myoclonus epilepsy (PME)."6.82A systematic review of the efficacy of perampanel as treatment for myoclonic seizures and symptomatic myoclonus ( Albaradie, R; Alghamdi, A; Alotaibi, M; Alotaibi, W; Bashir, S; Mir, A; Samreen, D, 2022)
"Levetiracetam (LEV) is a second-generation antiseizure medicine (ASM) with broad-spectrum efficacy and tolerability."5.62Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures. ( Abdelmesih, SK; Elkhateeb, N; Girgis, MY; Zakaria, M, 2021)
" As adjunctive therapies, topiramate ranked best for GTCA as well as overall for IGEs, while levetiracetam ranked best for myoclonic seizures."5.41Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis. ( Chu, H; Shi, J; Yang, X; Zhang, X; Zhou, Z, 2023)
"The incidence of seizures, their expression pattern and their latencies were registered and the severity was expressed by means of a five-point scale."5.39Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats. ( Bialer, M; Hen, N; Kubová, H; Mareš, P; Yagen, B, 2013)
"Acute pancreatitis is rarely seen in children, and it is often drug induced."5.35Acute hemorrhagic pancreatitis due to the use of valproic acid in a child. ( Köse, G; Ozaydin, E; Yükselgüngör, H, 2008)
"Myoclonus and seizures disappeared after discontinuation of L-dopa and the introduction of valproate sodium (VPA)."5.29Myoclonus and seizures in a patient with parkinsonism: induction by levodopa and its confirmation on SEPs. ( Hamada, T; Matsuura, T; Moriwaka, F; Tashiro, K; Yoshida, K, 1993)
"To explore the efficacy and safety of the combined therapy of valproic acid (VPA) and lamotrigine (LTG) for various types of epilepsy."5.16[Efficacy and safety of the combined therapy of valproic acid and lamotrigine for epileptics]. ( Hu, Q; Kang, HC; Li, X; Liu, XY; Liu, ZG; Wang, M; Xu, F; Zeng, Z; Zhu, SQ, 2012)
" This paper presents an analysis of body weight data gathered during a randomized trial comparing valproate with carbamazepine in 260 children aged 4-15 years with newly-diagnosed epilepsy."5.08Weight gain with valproate or carbamazepine--a reappraisal. ( Easter, D; O'Bryan-Tear, CG; Verity, C, 1997)
"To review the time to treatment failure, remission and first seizure of sodium valproate compared to phenytoin when used as monotherapy in people with focal onset seizures or generalised tonic-clonic seizures (with or without other generalised seizure types)."4.98Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nevitt, SJ; Tudur Smith, C; Weston, J, 2018)
"To review the time to withdrawal, remission and first seizure of phenytoin compared to valproate when used as monotherapy in people with partial onset seizures or generalised tonic-clonic seizures (with or without other generalised seizure types)."4.93Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review. ( Marson, AG; Nolan, SJ; Tudur Smith, C; Weston, J, 2016)
"To review the best evidence comparing phenytoin and valproate when used as monotherapy in individuals with partial onset seizures or generalised onset tonic-clonic seizures with or without other generalised seizure types."4.89Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. ( Marson, AG; Nolan, SJ; Pulman, J; Tudur Smith, C, 2013)
"In this systematic review we present information relating to the effectiveness and safety of the following interventions: monotherapy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs (lamotrigine or levetiracetam) for drug-resistant epilepsy; and hemispherectomy for drug-resistant epilepsy."4.88Epilepsy (generalised). ( Maguire, M; Marson, AG; Ramaratnam, S, 2012)
"In this systematic review we present information relating to the effectiveness and safety of the following interventions: monotherapy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs (lamotrigine or levetiracetam) for drug-resistant epilepsy; and hemispherectomy for drug-resistant epilepsy."4.86Epilepsy (generalised). ( Maguire, M; Marson, AG; Ramaratnam, S, 2010)
"To review the best evidence comparing phenytoin and valproate when used as monotherapy in subjects with partial onset seizures, or generalized onset tonic-clonic seizures with or without other generalized seizure types."4.81Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. ( Marson, AG; Tudur Smith, C; Williamson, PR, 2001)
"To evaluate the changes of epileptiform activity index (EAI) as a measure of the efficacy and tolerability of treatment with valproic acid (VA) in patients with newly-diagnosed generalized and focal epilepsy."3.96[Dynamics of epileptiform activity, efficacy and tolerability of valproic acid in adults and adolescents with newly-diagnosed epilepsy]. ( Karlov, VA; Kozhokaru, AB; Orlova, AS; Pushkar, TN; Vlasov, PN, 2020)
"To investigate the presence of insulin resistance in obese children with idiopathic epilepsy on valproic acid (VPA) monotherapy in comparison to obese otherwise healthy subjects."3.81Insulin resistance in patients on valproic acid: relation to adiponectin. ( Aly, RH; Amr, NH; Megahed, AA; Saad, WE, 2015)
"This study, in a meaningful number of exposed pregnancies, confirms a low risk for MCM with levetiracetam monotherapy use in pregnancy."3.79Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. ( Craig, J; Delanty, N; Hunt, SJ; Irwin, B; Liggan, B; Mawhinney, E; Morrison, PJ; Morrow, J; Parsons, L; Russell, A; Smithson, WH, 2013)
" Antiepileptics (carbamazepine, sodium valproate, zonisamide, clobazam, and topiramate), which are used for complex partial epilepsy or secondary generalized epilepsy in clinical practice, were orally administrated to kindled rats."3.76The usefulness of olfactory bulb kindling as a model for evaluation of antiepileptics. ( Akagi, M; Fujiwara, A; Ishikawa, T; Kaida, Y; Kamei, C; Takechi, K; Watanabe, Y, 2010)
" MET test (PTZ at the dose of 70 mg/kg) acute seizures in Wistar rats, in comparison to valproic acid (VPA)."3.76Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats. ( Arcieri, S; Coppola, G; D'Aniello, A; Messana, T; Pascotto, A; Signoriello, G; Verrotti, A, 2010)
"A child with Sturge-Weber syndrome and a left occipital leptomeningeal angioma developed focal seizures at 6 years of age that responded initially to oxcarbazepine."3.74Myoclonic-astatic epilepsy in a child with Sturge-Weber syndrome. ( Comi, AM; Ewen, JB; Kossoff, EH, 2007)
"Reversible neurotoxic symptoms were observed in three adult patients with absence status epilepticus on lamotrigine (LTG) therapy after administration of an IV bolus followed by oral valproic acid (VPA)."3.72Neurotoxicity following addition of intravenous valproate to lamotrigine therapy. ( Burneo, JG; Faught, E; Knowlton, RC; Kuzniecky, RI; Lawn, N; Limdi, N; Mendez, M; Prasad, A; Welty, TE, 2003)
"We report the case of a 4-year-old boy with long-term sodium valproate (valproic acid; VPA) therapy who suddenly developed clinically relevant thrombocytopenia and signs of hepatotoxicity."3.72Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment? ( Lackmann, GM, 2004)
"The study aimed at a comparative analysis of safety and efficacy of valproic acid (valproate) and barbiturates in the treatment of epilepsy in children."3.72[Efficacy and safety of antiepileptic therapy in children (a comparative analysis of valproates and barbiturates)]. ( Petrukhin, AS; Pylaeva, OA; Voronkova, KV, 2004)
"A 28-year-old patient with a 5-year history of bipolar disorder developed signs of encephalopathy 2 weeks after the addition of valproic acid to his treatment regimen of doxepine, risperidone, and biperidene."3.70[Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy]. ( Rottach, KG; Schmauss, M; Weiss-Brummer, J; Wieland, U, 2000)
" Following treatment with antiepileptic drugs (AEDs), the patient developed several rare complications: after beginning therapy with phenytoin, the patient developed pseudolymphoma; after monotherapy with carbamazepine (CBZ), the patient thereafter developed myoclonic jerks of upper and lower limbs upon awakening; after one year of treatment with valproate (VPA) the patient developed clinical and immuno-haematological signs of SLE."3.69Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p. ( Diomedi, M; Gigli, GL; Masala, C; Placidi, F; Pomponi, MG; Scalise, A; Silvestri, G, 1996)
"Valproic acid induced coma is presented in an adult patient without a history of metabolic disease."3.68Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma. ( Colombo, JP; Straver, JS; van der Vijver, JC; van Woerkom, TC; Verbiest, HB, 1992)
"Rare case reports describe genetic generalized epilepsy (GGE) starting de novo in people ≥50 years of age (older adults and the elderly)."3.01Extreme late onset of genetic generalized epilepsy in older adults and the elderly: A cohort study and literature review. ( Alzahrany, M; Punia, V, 2023)
"Levetiracetam was dominated by valproate in the cost-utility analysis, with a negative incremental net health benefit of -0·040 (95% central range -0·175 to 0·037) and a probability of 0·17 of being cost-effectiveness at a threshold of £20 000 per quality-adjusted life-year."3.01The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. ( Appleton, R; Baker, GA; Balabanova, S; Brown, R; Burnside, G; Hindley, D; Howell, S; Hughes, DA; Leach, JP; Maguire, M; Marson, A; Mohanraj, R; Plumpton, C; Sills, G; Smith, D; Smith, PE; Taylor, C; Tudur-Smith, C; Williamson, P, 2021)
"Epileptic myoclonus or myoclonic seizures can occur in idiopathic generalized epilepsy (IGE) and progressive myoclonus epilepsy (PME)."2.82A systematic review of the efficacy of perampanel as treatment for myoclonic seizures and symptomatic myoclonus ( Albaradie, R; Alghamdi, A; Alotaibi, M; Alotaibi, W; Bashir, S; Mir, A; Samreen, D, 2022)
" Mean VPA dosage was of approximately 870 mg/day (approximately 22 mg/kg/day) and mean VPA concentration was of approximately 89 mg/l at 12 h post-dose and of 54 mg/l at 24 h post-dose."2.72Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics. ( Adín, J; Armijo, JA; Arteaga, R; Herranz, JL, 2006)
"100 children with the first episode of febrile seizures (from 6 months to 4 years old) were investigated."2.71[Mexidol in treatment of children with generalized epilepsy and febrile seizures]. ( Kapanadze, N; Natriashvili, G; Natriashvili, S, 2005)
" The rate of patients discontinuing treatment due to adverse events or a lack of efficacy was 19% with CBZ compared to 9% with LTG (not statistically different)."2.71The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. ( Bergmann, L; Kurlemann, G; Schmitz, B; Siemes, H; Steinhoff, BJ; Ueberall, MA, 2005)
"Weight gain is a common side effect of valproate treatment."2.69Weight gain associated with valproate in childhood. ( Aysun, S; Demir, E, 2000)
"Oxcarbazepine (OXC) has been licensed as monotherapy and add-on treatment in epilepsy patients with partial seizures with or without secondarily generalized seizures (PS) and generalized tonic-clonic seizures without partial onset (GTCS)."2.68A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. ( Brodie, MJ; Christe, W; Krämer, G; Moore, A; Pohlmann, H; Steinhoff, BJ; Vigonius, U, 1997)
" Recommendations are made for a higher initial dosage regime for sodium valproate in partial seizures."2.67A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. ( Cartlidge, NE; Davidson, DL; Easter, DJ; Richens, A, 1994)
"Felbamate (FBM) is a new antiepileptic drug (AED) that has been tested in open and controlled studies in patients with therapy-refractory partial-onset seizures."2.67Felbamate in the treatment of refractory partial-onset seizures. ( Jensen, PK, 1993)
"A prospective clinical pharmacokinetic study was carried out in 10 adult patients with primary or secondary generalized tonic-clonic seizures on the efficacy of valproic acid (VPA) administered as a single daily dose in comparison with divided doses thrice daily."2.67[A single daily dose with valproic acid. A pharmacodynamic and clinical study]. ( Mamoli, B; Pelzl, G, 1992)
"Ninety four patients of generalised and partial epilepsy were randomly assigned to treatment with sodium valproate (49 cases) or phenytoin (45 cases)."2.67Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy. ( Agarwala, RK; Mehrotra, TN; Rastogi, P; Singh, VS, 1991)
"These patients with refractory generalized epilepsy with sleep-related fast activities do not belong to a well-established syndromic category."2.66Genetic/idiopathic generalized epilepsies: Not so good as that! ( Crespel, A; Gelisse, P; Nilo, A, 2020)
"VPA is widely used for the treatment of generalized epilepsy."2.61[Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy]. ( Araki, M; Mukai, T; Naka, H; Shishido, T; Tokinobu, H; Yamada, H, 2019)
"Epilepsy is a common neurological condition with a worldwide prevalence of around 1%."2.55Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. ( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017)
"Epilepsy is a common neurological condition with a worldwide prevalence of around 1%."2.55Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. ( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017)
"Occurrence of generalized tonic-clonic seizures (GTCS) is one of the most important risk factors of seizure-related complications and comorbidities in patients with epilepsy."2.50Pharmacotherapy for tonic-clonic seizures. ( Rheims, S; Ryvlin, P, 2014)
"Juvenile myoclonic epilepsy is a common idiopathic generalized epileptic syndrome that includes generalized myoclonic seizures and commonly generalized tonic-clonic and generalized absence seizures."2.45The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? ( Abou-Khalil, B; Montouris, G, 2009)
"Most idiopathic generalized epilepsy (IGE) begins in childhood."2.43Management guidelines for children with idiopathic generalized epilepsy. ( Camfield, C; Camfield, P, 2005)
"We related seizure control to VPA doses through uni- and multivariate statistical analyses."1.91Minimum effective sodium valproate dose in genetic generalized epilepsies. ( Bittar Guaranha, MS; Duarte, JTC; Guilhoto, LM; Hackbart, BA; Marques, VD; Peixoto-Santos, JE; Yacubian, EMT, 2023)
"We present two cases of arginase deficiency with genetically confirmed ARG1 mutation in one and biochemical confirmation in both."1.91Arginase deficiency-An unheralded cause of developmental epileptic encephalopathy. ( Banerjee, M; Fasaludeen, A; Jose, M; Menon, RN; Pavuluri, H; Radhakrishnan, A; Sundaram, S, 2023)
"Idiopathic generalized epilepsy with phantom absences, absence status, and generalized tonic-clonic seizures is an extremely rare condition."1.91Idiopathic generalized epilepsy with phantom absences, absence status, and generalized tonic-clonic seizures: A case report. ( Jiang, Y; Zhou, X, 2023)
"We examined 60 patients with genetic generalized epilepsy (GGE) aged 8-17 years."1.72Evaluation of optical coherence tomography findings in adolescents with genetic generalized epilepsy. ( Kaplan, AT; Oskan Yalcın, S; Sager, SG, 2022)
"Idiopathic Generalized Epilepsy (IGE) patients may not achieve optimal seizure control with monotherapy."1.72Seizure control in mono- and combination therapy in a cohort of patients with Idiopathic Generalized Epilepsy. ( Castro, LHM; Pipek, HZ; Pipek, LZ, 2022)
"Female patients with genetic generalized epilepsy who were followed up in our centre were included in the study."1.72Our reasons for converting to valproic acid treatment in female patients with genetic generalized epilepsy: a retrospective, single-centre study. ( Baklan, B; Mermi Dibek, D; Öztura, İ, 2022)
"Herein, we present a 13-year-old generalized epilepsy patient with eating-induced generalized seizures since the age of 5."1.62Eight years follow-up of a generalized epilepsy patient with eating-induced late-onset epileptic spasms and atypical absence with myoclonic jerks. ( Chen, B; Jin, L; Liu, Y; Wang, X; Zhang, W, 2021)
"Under lamotrigine, seizure aggravation was observed in 15 patients (two patients during levetiracetam, one patient during zonisamide, none during phenobarbital and valproic acid)."1.62Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy. ( Beier, CP; Gesche, J; Hjalgrim, H; Rubboli, G, 2021)
"Four (80%) had a referral diagnosis of focal epilepsy based on historical focal features with exacerbation of seizures on oxcarbazepine."1.62Unmasking the entity of 'drug-resistant' perioral myoclonia with absences: the twitches, darts and domes! ( Er, S; Menon, RN; Radhakrishnan, A; Rudrabhatla, PK, 2021)
"Levetiracetam (LEV) is a second-generation antiseizure medicine (ASM) with broad-spectrum efficacy and tolerability."1.62Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures. ( Abdelmesih, SK; Elkhateeb, N; Girgis, MY; Zakaria, M, 2021)
"We also studied the seizure outcome in patients with IGEs."1.56Tonic-clonic seizures in idiopathic generalized epilepsies: Prevalence, risk factors, and outcome. ( Asadi-Pooya, AA; Homayoun, M, 2020)
"Levetiracetam was preferred as an add-on therapy for both generalized and focal epilepsy."1.56Treatment of epilepsy in adults: Expert opinion in South Korea. ( Byun, JI; Cho, YW; Kang, KW; Kim, D; Kim, DW; Kim, JM; Kim, KT; Lee, ST; No, YJ; Seo, JG; Yang, KI, 2020)
"Idiopathic Generalized Epilepsy (IGE) management has become increasingly challenging due to the restricted use of Valproate (VPA) in females."1.56Valproate impact and sex-dependent seizure remission in patients with idiopathic generalized epilepsy. ( Albini, M; Barone, FA; Casciato, S; Cerulli Irelli, E; Cocchi, E; Di Bonaventura, C; Di Gennaro, G; Fanella, M; Fattouch, J; Fisco, G; Giallonardo, AT; Manfredi, M; Mascia, A; Morano, A; Orlando, B, 2020)
"The most common syndrome was juvenile myoclonic epilepsy (JME), diagnosed in 44."1.56Persistent treatment resistance in genetic generalized epilepsy: A long-term outcome study in a tertiary epilepsy center. ( Barone, FA; Cerulli Irelli, E; Di Bonaventura, C; Fanella, M; Fattouch, J; Fisco, G; Giallonardo, AT; Manfredi, M; Morano, A; Orlando, B, 2020)
"Topiramate was more likely prescribed for those with comorbid headache or migraine (incident: 335 of 1251 [26."1.51Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy. ( Faught, E; Fishman, J; Kalilani, L; Kim, H; Thurman, DJ, 2019)
"Ataxia was observed in 7/34 cases."1.48Defining the phenotypic spectrum of SLC6A1 mutations. ( Abi-Warde, MT; Afenjar, A; Bird, LM; Carvill, GL; Chae, JH; Chelly, J; Choi, M; Christensen, J; Courage, C; Czapansky-Beilman, D; de Saint Martin, A; Devinsky, O; Doummar, D; Dubbs, H; Gardella, E; Gleeson, JG; Helbig, I; Helbig, KL; Hopkins, S; Johannesen, KM; Keren, B; Lehesjoki, AE; Lesca, G; Linnankivi, T; Mecarelli, O; Mefford, HC; Merritt, JL; Mignot, C; Millichap, JJ; Myers, CT; Møller, RS; Nava, C; Nespeca, M; Pal, DK; Pendziwiat, M; Pisani, L; Piton, A; Reichert, SC; Rodan, LH; Rubboli, G; Schaefer, E; Schelhaas, HJ; Shaw, JE; Specchio, N; Striano, P; Tan, WH; Tang, S; Trivisano, M; Verhoeven, JS; Weber, YG; Yoo, Y, 2018)
"Eslicarbazepine acetate is a recently approved antiepileptic drug that is rapidly metabolized to (S)-licarbazepine."1.42Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy. ( Kim, TH; Petrou, S; Reid, CA, 2015)
"The boy is currently seizure-free under valproic acid, after twelve months of follow-up."1.42A child with ictal vocalizations and generalized epilepsy. ( Heritier Barras, AC; Korff, CM; Kurian, M, 2015)
"Fifty-four patients were included, with juvenile myoclonic epilepsy (JME) in 23 (42."1.40Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies. ( Aiguabella, M; Falip, M; Juvany, R; Leiva, E; Miró, J; Salas-Puig, J; Santurino, M; Veciana, M, 2014)
"Beckwith-Wiedemann syndrome (BWS) is etiologically connected with genetic/epigenetic growth dysregulation."1.40[Case of combination of Beckwith-Wiedemann syndrome with West syndrome]. ( Globa, OV; Kremenchugskaya, MR; Kuzenkova, LM; Podkletnova, TV, 2014)
"The incidence of seizures, their expression pattern and their latencies were registered and the severity was expressed by means of a five-point scale."1.39Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats. ( Bialer, M; Hen, N; Kubová, H; Mareš, P; Yagen, B, 2013)
"Among those with Idiopathic Generalized Epilepsy (46%), generalized tonic clonic seizure was encountered in 74% and absence seizure was observed in 13%."1.39Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital. ( Chowdhury, AH; Chowdhury, RN; Ghose, SK; Habib, M; Haque, B; Hasan, AT; Hoque, A; Khan, SU; Mohammad, QD; Mondal, BA; Rahman, KM, 2013)
"Idiopathic generalized epilepsy (IGE) resistant to treatment is common, but its neuronal correlates are not entirely understood."1.39Reduced default mode network connectivity in treatment-resistant idiopathic generalized epilepsy. ( DiFrancesco, MW; Gotman, J; Holland, SK; Kay, BP; Privitera, MD; Szaflarski, JP, 2013)
"Up to 30% of patients with idiopathic generalized epilepsy (IGE) have seizures that are refractory to medication despite appropriate therapy that commonly includes valproate (VPA)."1.39The relationship between the localization of the generalized spike and wave discharge generators and the response to valproate. ( Gotman, J; Holland, SK; Kay, B; Privitera, MD; Szaflarski, JP, 2013)
"We report a child with idiopathic generalized epilepsy who developed myoclonic seizures and had an abnormal electroencephalogram (EEG) when oral suspension of OXC was introduced."1.38Myoclonus precipitated by oral suspension of oxcarbazepine in idiopathic generalized epilepsy. ( Deng, S; Huang, L; Luo, R; Mao, M, 2012)
"Idiopathic generalized epilepsy (IGE) was diagnosed in 85 cases, cryptogenic focal epilepsy in 107 cases, symptomatic focal epilepsy in 51 cases, unclassified epilepsy in 32 cases."1.38[Idiopathic generalized epilepsy in young women: choise of treatment strategy]. ( Kotov, AS, 2012)
"Valproic acid (VPA) is a first-line antiepileptic drug for therapy of patients with IGE."1.37Valproate reduces spontaneous generalized spikes and waves but not photoparoxysmal reactions in patients with idiopathic generalized epilepsies. ( Boor, R; Ettle, E; Muhle, H; Siniatchkin, M; Stephani, U, 2011)
"Sparse information on dose-response characteristics for initial antiepileptic drug monotherapy in children with idiopathic generalized epilepsy (IGE) is available."1.36Valproate in children with newly diagnosed idiopathic generalized epilepsy. ( Glauser, TA; Holland, KD; Monahan, S; Morita, D; Vartzelis, G, 2010)
"Prednisolone was tapered to 20 mg/day for 5 months."1.36Rheumatoid leptomeningitis: radiological alteration of cerebral hypoperfusion and subarachnoid lesions. ( Ikeda, K; Ishikawa, Y; Ito, H; Iwasaki, Y; Kawabe, K; Miura, K; Takazawa, T; Yoshii, Y, 2010)
"Valproic acid (VPA) is a major antiepileptic drug (AED) with efficacy against multiple seizure types."1.35Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases? ( Czapp, M; Hoffmann, K; Löscher, W, 2008)
"Epilepsy was most common among those with maternal deletions and unknown subtypes, with catastrophic epilepsies present in only these two subtypes."1.35Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options. ( Braun, EK; Bruno, P; Conant, KD; Nespeca, MP; Said, RR; Thibert, RL; Thiele, EA, 2009)
"In this study 27 patients with focal or generalized epilepsy receiving a single dosage of prolonged-release valproate given in the evening were included."1.35Once daily monotherapy with prolonged-release valproate minitablets given in the evening--a chronopharmacological study. ( Fraunberger, B; Graf, W; Kerling, F; Pauli, E; Stefan, H; Yang, T, 2009)
"Acute pancreatitis is rarely seen in children, and it is often drug induced."1.35Acute hemorrhagic pancreatitis due to the use of valproic acid in a child. ( Köse, G; Ozaydin, E; Yükselgüngör, H, 2008)
"Visual auras are reported to be uncommon or rare in patients with idiopathic generalized epilepsy."1.35[Visual auras in idiopathic generalized epilepsy]. ( Coubes, P; Crespel, A; Gelisse, P, 2008)
"Primary generalized epilepsy may be the result of maldevelopment of central nervous system and each seizure may be the consequence of a neuronal maladaptation to an unknown stimulus using the paleospinothalamical tract due to an overexpression of brain-derived neurotrophic factor and neurotrophin-3."1.33The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate. ( Toth, M, 2005)
" The dosage schedule was: 5 mg every day or every second day for 14 days, increased by 5 mg every 14th day to 25 mg a day."1.33Lamotrigine-induced rash--worth a rechallenge. ( Dam, M; P-Codrea Tigaran, S; Sidenius, P, 2005)
"A diagnosis of generalized NCSE with tonic seizures was made on the basis of the clinical picture and response to barbiturate anaesthetic, although the EEG pattern was not typical of the changes previously described in tonic seizures-tonic status epilepticus."1.33Prolonged postictal stupor: nonconvulsive status epilepticus, medication effect, or postictal state? ( Chattopadhyay, A; Kuc, S; Langheinrich, TC; Reuber, M, 2005)
" Resting EEG with 19 channels was investigated before and during chronic administration of valproate (VPA)."1.33Distribution of spatial complexity of EEG in idiopathic generalized epilepsy and its change after chronic valproate therapy. ( Clemens, B; Czopf, J; Gyimesi, C; Kondakor, I; Toth, M; Wackermann, J, 2005)
"thirty patients with generalized epilepsy were studied at baseline, and re-examined 4 (S1) and 25 (S2) weeks after the administration of valproate (mean dose: 1040 +/- 284 mg)."1.33The effect of valproate on silent period and corticomotor excitability. ( Divanoglou, D; Kazis, A; Kazis, DA; Kimiskidis, VK; Mills, KR; Papagiannopoulos, S; Sotirakoglou, K; Vlaikidis, N, 2006)
"One hundred seventy-eight men had focal epilepsy (117 of these had temporal lobe epilepsy [TLE]) and 22 idiopathic generalized epilepsy (IGE)."1.32Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. ( Bauer, J; Blumenthal, S; Reuber, M; Stoffel-Wagner, B, 2004)
"Men with epilepsy have reduced fertility, and antiepileptic drugs may affect semen quality."1.32Effect of epilepsy and antiepileptic drugs on male reproductive health. ( Isojärvi, JI; Juntunen, KS; Löfgren, E; Päivänsalo, M; Pakarinen, AJ; Rautakorpi, I; Tuomivaara, L, 2004)
"The recommended treatment for juvenile myoclonic epilepsy (JME) is valproate (VPA)."1.32Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. ( Hardison, H; Khurana, DS; Kothare, SV; Legido, A; Melvin, JJ; Valencia, I, 2004)
"A 25-year-old girl with mild mental retardation had a 6-year history of absence seizures, with occasional head drop."1.31Mild generalized epilepsy and developmental disorder associated with large inv dup(15). ( Canevini, MP; Canger, R; Cavani, S; Chifari, R; Elia, M; Guerrini, R; Pierluigi, M; Sgrò, V, 2002)
"The complex relationship between migraine and epilepsy is highlighted by the occurrence of a seizure during a migraine attack without aura."1.31Migraine-associated seizure: a case of reversible MRI abnormalities and persistent nondominant hemisphere syndrome. ( Dodick, DW; Friedenberg, S, 2000)
"an elderly patient presented with acute confusion and was found to have nonconvulsive status epilepticus."1.31Nonconvulsive status epilepticus causing acute confusion. ( Mitchell, SC; Pollock, LM, 2000)
"Idiopathic generalized epilepsy presenting with hemiconvulsive seizures has not, to our knowledge, been previously described."1.31Idiopathic generalized epilepsy presenting with hemiconvulsive seizures. ( Kiley, MA; Sander, JW; Smith, SJ, 2000)
"Seven patients had comorbid psychiatric disorders, whereas six patients had epilepsy (three rolandic, two generalized, and one indeterminate)."1.31Pediatric migraine prophylaxis with divalproex. ( Drake, ME; Greenberg, G; Pakalnis, A; Paolichi, J, 2001)
"Metopic craniosynostosis may be an adverse effect of valproic acid exposed fetus."1.31[Metopic craniosynostosis, probable effect of intrauterine exposure to maternal valproate treatment]. ( Bensouda, B; Bruel, H; Chabrolle, JP; Degre, S; Ickowicz, V; Poinsot, J; Simon, A, 2001)
"Zonisamide was changed to sodium valproate."1.31Smoldering myeloma associated with zonisamide treatment. ( Ando, Y; Asai, S; Hotta, T; Kobayashi, H; Miyachi, H, 2002)
"Stomatitis is a rare but potentially serious adverse effect of divalproex sodium administration."1.31Valproate-associated stomatitis. ( Baker, C; Baumann, RJ; Miller, CS; Ryan, M, 2002)
" The purpose of our study was to evaluate the effects of chronic administration of valproate (VPA), phenytoin (PHT), and MK-801 on the change in seizure phenotype observed in our model system."1.30Effects of valproate, phenytoin, and MK-801 in a novel model of epileptogenesis. ( Applegate, CD; Ozduman, K; Samoriski, GM, 1997)
" Toxic damage of CNS was the most significant."1.30[Side effects of anticonvulsants in the treatment of idiopathic generalized epilepsy]. ( Mukhin, KIu; Petrukhin, AS; Rykova, EA, 1997)
"Epilepsy is a relatively common problem in children, adults and the elderly."1.30Treatment of the epileptic patient in the dental office. ( Haller, JS; Kennedy, BT, 1998)
"A child with primary ciliary dyskinesia syndrome (PCDS) developed primary generalised epilepsy (PGE)."1.30Primary ciliary dyskinesia syndrome and primary generalised epilepsy. ( Shepherd, RC, 1999)
" Significant correlations between platelet count, aggregation, and ATP release and VPA dosage and plasma concentration were also observed."1.30Platelet count and function in children receiving sodium valproate. ( Altobelli, E; Chiarelli, F; Greco, R; Matera, V; Morgese, G; Verrotti, A, 1999)
"When phenytoin was discontinued, valproate levels increased, and he progressively improved."1.30Exceptionally long absence status: multifactorial etiology, drug interactions and complications. ( Andermann, F; Bastos, A; D'Agostino, MD; Dubeau, F; Fedi, M, 1999)
"Carbamazepine treatment resulted in prolongation of peak latencies of waves I-III-V and interpeak intervals I-III and I-V."1.29Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children. ( Cenani, A; Dirican, A; Keskin, G; Senocak, D; Sozuer, D; Yalcin, E; Yuksel, A, 1995)
"In all experiments, the PTZ seizure threshold was repeatedly determined in individual rats with chronically implanted catheters at daily intervals."1.29Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous ("controlled release") administration in a model of generalized seizures in rats. ( Hönack, D; Löscher, W, 1995)
"Lamotrigine was well tolerated."1.29Lamotrigine as an add-on drug in typical absence seizures. ( Ferrie, CD; Knott, C; Panayiotopoulos, CP; Robinson, RO, 1995)
"Myoclonus and seizures disappeared after discontinuation of L-dopa and the introduction of valproate sodium (VPA)."1.29Myoclonus and seizures in a patient with parkinsonism: induction by levodopa and its confirmation on SEPs. ( Hamada, T; Matsuura, T; Moriwaka, F; Tashiro, K; Yoshida, K, 1993)
"However, the hydrocephalus remained stable even when the shunt was removed due to infection."1.28[A case of Klippel-Trenaunay-Weber syndrome accompanied by congenital hydrocephalus and micropolygyria]. ( Araki, R; Koide, H; Miyaji, T; Shime, H; Shioda, K, 1992)

Research

Studies (243)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's56 (23.05)18.2507
2000's76 (31.28)29.6817
2010's68 (27.98)24.3611
2020's43 (17.70)2.80

Authors

AuthorsStudies
Kaplan, AT1
Oskan Yalcın, S1
Sager, SG1
Kiiski, R1
Basnyat, P1
Raitanen, J1
Rainesalo, S1
Peltola, J1
Mäkinen, J1
Ozyurek, H1
Bayrak, I1
Yayici Koken, O1
Ince, H1
Tasdemir, HA1
Aydin, OF1
Hochbaum, M1
Kienitz, R1
Rosenow, F1
Schulz, J1
Habermehl, L1
Langenbruch, L1
Kovac, S1
Knake, S1
von Podewils, F1
von Brauchitsch, S1
Hamacher, M1
Strzelczyk, A1
Willems, LM1
Yang, H1
Liao, H1
Gan, S1
Xiao, T1
Wu, L1
Mir, A1
Alghamdi, A1
Alotaibi, W1
Samreen, D1
Alotaibi, M1
Albaradie, R1
Bashir, S1
Pipek, LZ1
Pipek, HZ1
Castro, LHM1
Ascoli, M1
Elia, M2
Gasparini, S1
Bonanni, P1
Mastroianni, G1
Cianci, V1
Neri, S1
Pascarella, A1
Santangelo, D1
Aguglia, U2
Ferlazzo, E2
Hamed, SA1
Osiely, AM1
Bleakley, LE1
McKenzie, CE1
Reid, CA2
Alzahrany, M1
Punia, V1
van der Meer, PB1
Dirven, L1
Fiocco, M1
Vos, MJ1
Kouwenhoven, MCM1
van den Bent, MJ1
Taphoorn, MJB1
Koekkoek, JAF1
Marques, VD1
Hackbart, BA1
Guilhoto, LM1
Duarte, JTC1
Peixoto-Santos, JE1
Yacubian, EMT1
Bittar Guaranha, MS1
Pavuluri, H1
Jose, M1
Fasaludeen, A1
Sundaram, S1
Radhakrishnan, A3
Banerjee, M1
Menon, RN3
Chu, H1
Zhang, X1
Shi, J1
Zhou, Z1
Yang, X2
Fantaneanu, TA1
Thornton, HF1
Zhang, T1
Bercovici, E1
Hrazdil, C1
Ikeda, KM1
Kassiri, J1
Suller Marti, A1
Pana, R1
Rezazadeh, A1
Kobayashi, E1
Bui, E1
Jiang, Y1
Zhou, X1
Brigo, F1
Striano, P4
Belcastro, V1
Tabrizi, N1
Zarvani, A1
Rezaei, P1
Cheraghmakani, H1
Alizadeh-Navaei, R1
Cerulli Irelli, E3
Morano, A3
Cocchi, E2
Casciato, S2
Fanella, M3
Albini, M2
Avorio, F1
Basili, LM1
Fisco, G3
Barone, FA3
Mascia, A2
D'Aniello, A2
Manfredi, M3
Fattouch, J3
Quarato, P1
Giallonardo, AT3
Di Gennaro, G2
Di Bonaventura, C3
Asadi-Pooya, AA1
Homayoun, M1
Andreasson, AC1
Sigurdsson, GV1
Pegenius, G1
Thordstein, M1
Hallböök, T1
Byun, JI1
Kim, DW1
Kim, KT1
Yang, KI1
Lee, ST1
Seo, JG1
No, YJ1
Kang, KW1
Kim, D1
Kim, JM1
Cho, YW1
Toledo, M3
Mostacci, B2
Bosak, M1
Jedrzejzak, J1
Thomas, RH1
Salas-Puig, J5
Biraben, A1
Schmitz, B3
Wolking, S1
Schulz, H1
Nies, AT1
McCormack, M1
Schaeffeler, E1
Auce, P1
Avbersek, A1
Becker, F1
Klein, KM1
Krenn, M1
Møller, RS3
Nikanorova, M1
Weckhuysen, S1
Consortium, E1
Cavalleri, GL1
Delanty, N2
Depondt, C1
Johnson, MR1
Koeleman, BP1
Kunz, WS2
Marson, AG14
Sander, JW2
Sills, GJ1
Zara, F2
Zimprich, F1
Weber, YG3
Krause, R1
Sisodiya, S1
Schwab, M1
Sander, T2
Lerche, H2
Hamdy, MM1
Elfatatry, AM1
Mekky, JF1
Hamdy, E1
Nilo, A1
Gelisse, P2
Crespel, A2
Orlando, B2
Gesche, J4
Hjalgrim, H4
Rubboli, G4
Beier, CP4
Wu, K1
Hirsch, LJ1
Babl, FE1
Josephson, SA1
Karlov, VA3
Kozhokaru, AB1
Vlasov, PN2
Pushkar, TN1
Orlova, AS1
Wang, X3
Chen, B1
Jin, L1
Zhang, W1
Liu, Y1
Ranzato, F1
Giuliano, L1
La Neve, A1
Bilo, L1
Durante, V1
Ermio, C1
Monti, G1
Zambrelli, E1
Lodi, MAM1
Galimberti, CA1
Ballvé, A1
Quintana, M1
Campos, D1
Llauradó, A1
Raspall, M1
Fonseca, E1
Abraira, L1
Santamarina, E1
Marson, A2
Burnside, G1
Appleton, R3
Smith, D2
Leach, JP2
Sills, G1
Tudur-Smith, C1
Plumpton, C1
Hughes, DA1
Williamson, P1
Baker, GA2
Balabanova, S1
Taylor, C1
Brown, R1
Hindley, D1
Howell, S1
Maguire, M3
Mohanraj, R1
Smith, PE3
Rudrabhatla, PK1
Er, S1
Mermi Dibek, D1
Öztura, İ1
Baklan, B1
Atalar, AÇ1
Şirin, NG1
Bebek, N1
Baykan, B1
Steinbart, D1
Gaus, V1
Kowski, AB1
Holtkamp, M1
Pellegrino, F1
Tardivo, I1
Abdelmesih, SK1
Elkhateeb, N1
Zakaria, M1
Girgis, MY1
Hakami, T1
Coppola, G2
Piccorossi, A1
Operto, FF1
Verrotti, A4
Nevitt, SJ3
Sudell, M2
Weston, J4
Tudur Smith, C7
Salinas, FS1
Szabó, CÁ1
Tang, L1
Ge, L1
Wu, W1
Rui, P1
Wu, Y1
Yu, W1
Johannesen, KM1
Gardella, E1
Linnankivi, T1
Courage, C1
de Saint Martin, A1
Lehesjoki, AE1
Mignot, C1
Afenjar, A1
Lesca, G1
Abi-Warde, MT1
Chelly, J1
Piton, A1
Merritt, JL1
Rodan, LH1
Tan, WH1
Bird, LM1
Nespeca, M1
Gleeson, JG1
Yoo, Y1
Choi, M1
Chae, JH1
Czapansky-Beilman, D1
Reichert, SC1
Pendziwiat, M1
Verhoeven, JS1
Schelhaas, HJ1
Devinsky, O1
Christensen, J1
Specchio, N1
Trivisano, M1
Nava, C1
Keren, B1
Doummar, D1
Schaefer, E1
Hopkins, S1
Dubbs, H1
Shaw, JE2
Pisani, L1
Myers, CT1
Tang, S2
Pal, DK1
Millichap, JJ1
Carvill, GL1
Helbig, KL1
Mecarelli, O1
Helbig, I2
Mefford, HC2
Campos, MSA1
Ayres, LR1
Morelo, MRS1
Carizio, FAM1
Pereira, LRL1
Kim, H1
Faught, E2
Thurman, DJ1
Fishman, J1
Kalilani, L1
Olsen, D1
Baftiu, A1
Alvestad, S1
Bjørnvold, M1
Molteberg, E1
Lossius, M1
Landmark, CJ1
Yamada, H1
Shishido, T1
Mukai, T1
Araki, M1
Naka, H1
Tokinobu, H1
Sonmez, FM1
Serin, HM1
Alver, A1
Aliyazicioglu, R1
Cansu, A1
Can, G1
Zaman, D1
Mareš, P1
Kubová, H1
Hen, N1
Yagen, B1
Bialer, M1
Nolan, SJ2
Pulman, J1
Habib, M1
Khan, SU1
Hoque, A1
Mondal, BA1
Hasan, AT1
Chowdhury, RN1
Haque, B1
Rahman, KM1
Chowdhury, AH1
Ghose, SK1
Mohammad, QD1
Bonnett, LJ1
Williamson, PR4
Chadwick, D3
Miró, J1
Aiguabella, M1
Veciana, M1
Juvany, R1
Santurino, M1
Leiva, E1
Falip, M1
Rheims, S1
Ryvlin, P1
Cheuk, DK1
Wong, V1
Guo, J1
Wang, D1
Ren, M1
Xiong, B1
Li, Z1
Zeng, K1
Perry, G1
Brindley, LM1
Muthukumaraswamy, SD1
Singh, KD1
Hamandi, K1
Taskin, E1
Atli, B1
Kiliç, M1
Sari, Y1
Aydin, S1
Mole, TB1
Aly, RH1
Amr, NH1
Saad, WE1
Megahed, AA1
El-Farahaty, RM1
El-Mitwalli, A1
Azzam, H1
Wasel, Y1
Elrakhawy, MM1
Hasaneen, BM1
Steinborn, B1
Zarowski, M1
Winczewska-Wiktor, A1
Wójcicka, M1
Młodzikowska-Albrecht, J1
Losy, J1
Clemens, B3
Puskás, S1
Besenyei, M1
Kovács, NZ1
Spisák, T1
Kis, SA1
Emri, M1
Hollódy, K1
Fogarasi, A1
Kondákor, I2
Fekete, I1
Schmidt, D1
Kim, TH1
Petrou, S1
Kurian, M1
Heritier Barras, AC1
Korff, CM1
Kuzenkova, LM1
Kremenchugskaya, MR1
Globa, OV1
Podkletnova, TV1
Mundlamuri, RC1
Sinha, S1
Subbakrishna, DK1
Prathyusha, PV1
Nagappa, M1
Bindu, PS1
Taly, AB1
Umamaheswara Rao, GS1
Satishchandra, P1
Snehunsu, A1
Ghosal, C1
Kandwal, M1
Yadav, PK1
Nayak, BS1
Rao, KR1
Kamath, SU1
Sahoo, P1
Srinivasan, KK1
Naduvil Narayanan, S1
Kumar, S1
Joseph, A1
Martínez-Rivera, V1
Martínez-Antón, J1
Khanevski, M1
Solberg, C1
Hoffmann, K1
Czapp, M1
Löscher, W2
Moeller, JJ1
Rahey, SR1
Sadler, RM1
Thibert, RL1
Conant, KD1
Braun, EK1
Bruno, P1
Said, RR1
Nespeca, MP1
Thiele, EA1
Graf, W1
Fraunberger, B1
Yang, T1
Kerling, F1
Pauli, E1
Stefan, H1
Montouris, G1
Abou-Khalil, B1
Minetti, C1
Striano, S1
Fujiwara, A1
Watanabe, Y1
Takechi, K1
Ishikawa, T1
Kaida, Y1
Akagi, M1
Kamei, C1
Zheleznova, EV2
Kalinin, VV1
Zemlyanaya, AA1
Sokolova, LV2
Medvedev, IL1
Holland, KD1
Monahan, S1
Morita, D1
Vartzelis, G1
Glauser, TA1
Sleegers, MJ1
Beutler, JJ1
Hardon, WJ1
Berden, JH1
Verhave, JC1
Conemans, JM1
Hollander, DA1
Dautzenberg, PL1
Hoogeveen, EK1
Arcieri, S1
Messana, T1
Signoriello, G1
Pascotto, A1
Dennig, D2
Rating, D1
Steinhoff, BJ3
Mayer, T1
Kutschenko, A1
Nitsche, MA1
Sommer, M1
Gileles, E1
Paulus, W1
Ikeda, K1
Takazawa, T1
Ito, H1
Ishikawa, Y1
Miura, K1
Yoshii, Y1
Kawabe, K1
Iwasaki, Y1
Pulsipher, DT1
Dabbs, K1
Tuchsherer, V1
Sheth, RD1
Koehn, MA1
Hermann, BP1
Seidenberg, M1
Ramaratnam, S2
Muhle, H2
Ettle, E1
Boor, R1
Stephani, U2
Siniatchkin, M1
Hung, CC1
Ho, JL1
Chang, WL1
Tai, JJ1
Hsieh, TJ1
Hsieh, YW1
Liou, HH1
Aggarwal, A1
Rastogi, N1
Mittal, H1
Chillar, N1
Patil, R1
Cherian, A1
Baheti, NN1
Iyer, RS1
Rathore, C1
Deng, S1
Luo, R1
Mao, M1
Huang, L1
Lance, EI1
Shapiro, BK1
Kang, HC1
Hu, Q1
Liu, XY1
Xu, F1
Li, X1
Liu, ZG1
Zeng, Z1
Wang, M1
Zhu, SQ1
Trinka, E2
Van Paesschen, W1
Kälviäinen, R1
Marovac, J1
Duncan, B1
Buyle, S1
Hallström, Y1
Hon, P1
Muscas, GC1
Newton, M1
Meencke, HJ1
Pohlmann-Eden, B1
Freĭdkova, NV1
Rusanova, LV1
Kotov, AS1
Kaplan, PW1
Schlattman, DK1
Haerian, BS1
Baum, L1
Tan, HJ1
Kwan, P1
Raymond, AA1
Saruwatari, J1
Nakagawa, K1
Mohamed, Z1
Sönnichsen, AC1
Raspall-Chaure, M1
Lainez, E1
Macaya-Ruiz, A1
Roig-Quilis, M1
Kay, BP1
DiFrancesco, MW1
Privitera, MD2
Gotman, J2
Holland, SK2
Szaflarski, JP2
Kay, B1
Klitten, LL1
Trucks, H1
Franke, A1
Kautza, M1
Wolf, P1
Schreiber, S1
Rückert, IM1
Wichmann, HE1
Ernst, JP1
Schurmann, C1
Grabe, HJ1
Tommerup, N1
Mawhinney, E1
Craig, J2
Morrow, J2
Russell, A1
Smithson, WH1
Parsons, L1
Morrison, PJ1
Liggan, B1
Irwin, B1
Hunt, SJ1
Chifari, R1
Guerrini, R1
Pierluigi, M1
Cavani, S1
Sgrò, V1
Canger, R1
Canevini, MP1
Thibault, M1
Blume, WT1
Saint-Hilaire, JM1
Zakhari, R1
Sommerville, KW1
Clough, HE1
Hutton, JL2
Chadwick, DW2
Banerjea, MC1
Diener, W1
Kutschke, G1
Schneble, HJ1
Korinthenberg, R1
Sutor, AH1
Maksutova, EL1
Dilitz, E1
Unterberger, I1
Luef, G1
Deisenhammer, F1
Niedermüller, U1
Thaler, C1
Bauer, G1
Shahar, E3
Andraus, J2
Tanaka, M1
Inoue, Y1
Veggiotti, P1
Termine, C1
Granocchio, E1
Bova, S1
Papalia, G1
Lanzi, G1
Audic-Gerard, F1
Szepetowski, P1
Genton, P2
Barak, S2
Bourgeois, BF1
Wheless, JW1
Burneo, JG1
Limdi, N1
Kuzniecky, RI1
Knowlton, RC1
Mendez, M1
Lawn, N1
Welty, TE1
Prasad, A1
Mukhin, KIu2
Petrukhin, AS3
Mironov, MB1
Birnbaum, AK1
Kriel, RL1
Norberg, SK1
Wical, BS1
Le, DN1
Leppik, IE1
Cloyd, JC1
Simister, RJ1
McLean, MA1
Barker, GJ1
Duncan, JS3
Perunova, NIu1
Lackmann, GM1
Teich, M1
Longin, E1
Dempfle, CE1
König, S1
Gates, JR1
Bauer, J2
Blumenthal, S1
Reuber, M2
Stoffel-Wagner, B1
Isojärvi, JI3
Löfgren, E1
Juntunen, KS1
Pakarinen, AJ3
Päivänsalo, M1
Rautakorpi, I1
Tuomivaara, L1
Kramer, U1
Dhanaraj, M1
Jayavelu, A1
Pylaeva, OA1
Voronkova, KV1
Toth, M2
Oka, E1
Murakami, N1
Ogino, T1
Kobayashi, K1
Ohmori, I1
Akiyama, T1
Ito, M1
Fischer, W1
Kothare, SV1
Valencia, I1
Khurana, DS1
Hardison, H1
Melvin, JJ1
Legido, A1
P-Codrea Tigaran, S1
Sidenius, P1
Dam, M1
Gupta, M1
Aneja, S1
Kohli, K1
Natriashvili, G1
Natriashvili, S1
Kapanadze, N1
Langheinrich, TC1
Chattopadhyay, A1
Kuc, S1
Ueberall, MA1
Siemes, H1
Kurlemann, G1
Bergmann, L1
Zenkov, LR1
Camfield, C1
Camfield, P1
Benbadis, SR1
Wackermann, J1
Gyimesi, C1
Czopf, J1
Kazis, DA1
Kimiskidis, VK1
Papagiannopoulos, S1
Sotirakoglou, K1
Divanoglou, D1
Vlaikidis, N1
Mills, KR1
Kazis, A1
Herranz, JL2
Arteaga, R1
Adín, J1
Armijo, JA1
Unay, B1
Akin, R1
Sarici, SU1
Gok, F1
Kurt, I1
Gokcay, E1
Ewen, JB1
Comi, AM1
Kossoff, EH1
Al-Kharusi, AM1
Alwaidh, M1
Cramp, C1
Cockerell, OC1
Cooper, PN1
Doughty, J1
Eaton, B1
Gamble, C1
Goulding, PJ1
Howell, SJ1
Hughes, A1
Jackson, M1
Jacoby, A1
Kellett, M1
Lawson, GR1
Nicolaides, P1
Roberts, R1
Shackley, P1
Shen, J1
Smith, DF1
Smith, CT1
Vanoli, A1
Cowling, BJ1
Béla, C1
Mónika, B1
Márton, T1
István, K1
Ozaydin, E1
Yükselgüngör, H1
Köse, G1
Thomas, P1
Scardapane, A1
Franzoni, E1
Manco, R1
Chiarelli, F2
Rodríguez-Vázquez, M1
Carrascosa-Romero, MC1
Pardal-Fernández, JM1
Iniesta, I1
Coubes, P1
Schmidt, A1
Darius, J1
Brosz, M1
Roth, N1
Meyer, FP1
Kroker, S1
Wien, F1
Brett, B1
Yuksel, A1
Senocak, D1
Sozuer, D1
Keskin, G1
Dirican, A1
Cenani, A1
Yalcin, E1
Cruz-Flores, S1
Hayat, GR1
Mirza, W1
Hönack, D1
Keating, A1
Blahunka, P1
Marciani, MG1
Maschio, MC1
Spanedda, F1
Gigli, GL2
Bassetti, MA1
Bernardi, G1
Macdonald, RL1
Kelly, KM1
Shamansurov, ShSh1
Duval, X1
Chosidow, O1
Semah, F1
Lipsker, D1
Francès, C1
Herson, S1
Konishi, T2
Naganuma, Y2
Hongou, K1
Murakami, M2
Yamatani, M2
Okada, T2
Ferrie, CD1
Robinson, RO1
Knott, C1
Panayiotopoulos, CP1
Hongo, K1
Yagi, S1
Heller, AJ2
Chesterman, P1
Elwes, RD1
Crawford, P1
Johnson, AL1
Reynolds, EH2
Verity, CM1
Hosking, G1
Easter, DJ2
Callaghan, N1
Majeed, T1
O'Connell, A1
Oliveira, DB1
Vassella, F1
Penzien, J1
Hassink, RI1
Donati, F1
Riche, H1
Salord, F1
Jourdan, C1
Wertheimer, P1
Richens, A1
Davidson, DL1
Cartlidge, NE1
Reutens, DC1
Patsalos, PN1
Karpova, MN2
Pankov, OIu2
Germane, SK1
Klusha, VE1
Duburs, G1
Ribacoba Montero, R1
Salas Puig, J1
Ferreiro Martín, D1
Helmstaedter, C2
Wagner, G1
Elger, CE2
Jensen, PK1
Ono, K1
Baba, H1
Sugai, S1
Yoshida, K1
Moriwaka, F1
Matsuura, T1
Hamada, T1
Tashiro, K1
Laatikainen, TJ1
Juntunen, KT1
Myllylä, VV2
Bourgeois, B1
Drake, ME2
Reider, CR1
Kay, A1
Mauri, JA1
Iñiguez, C1
Jericó, I1
Díaz-Insa, S1
Abad, F1
Morales, F1
Scalise, A1
Silvestri, G1
Diomedi, M1
Placidi, F1
Pomponi, MG1
Masala, C1
Brasić, JR1
Barnett, JY1
Christe, W1
Krämer, G1
Vigonius, U1
Pohlmann, H1
Brodie, MJ2
Moore, A1
Easter, D1
O'Bryan-Tear, CG1
Verity, C1
Farrell, K1
Connolly, MB1
Munn, R1
Peng, S1
MacWilliam, LM1
Applegate, CD1
Samoriski, GM1
Ozduman, K1
Ribacoba, R1
Solar, DM1
Otero, B1
Scheen, AJ1
Rykova, EA1
Kennedy, BT1
Haller, JS1
Koepp, MJ1
Richardson, MP1
Brooks, DJ1
Cunningham, VJ1
Bleck, TP1
Diehl, B1
Wyllie, E1
Rothner, AD1
Bingaman, W1
Morrison, P1
Patterson, V1
Shepherd, RC1
Greco, R1
Matera, V1
Altobelli, E1
Morgese, G1
Supprian, T1
Retz, W1
Deckert, J1
Sleiman, C1
Raffy, O1
Roué, C1
Mal, H1
Rottach, KG1
Weiss-Brummer, J1
Wieland, U1
Schmauss, M1
Friedenberg, S1
Dodick, DW1
Demir, E1
Aysun, S1
D'Agostino, MD1
Andermann, F1
Dubeau, F1
Fedi, M1
Bastos, A1
Pollock, LM1
Mitchell, SC1
Kiley, MA1
Smith, SJ1
Conca, A1
Beraus, W1
König, P1
Waschgler, R1
Rättyä, J1
Turkka, J1
Knip, M1
Kotila, MA1
Lukkarinen, O1
Kmieć, T1
Jóźwiak, S1
Kuczyński, D1
Karkowska, B1
Bachański, M1
Guye, M1
Bartolomei, F1
Gastaut, JL1
Chauvel, P1
Dravet, C1
Perucca, E1
Pakalnis, A1
Greenberg, G1
Paolichi, J1
Bescoby-Chambers, N1
Forster, P1
Bates, G1
Chabrolle, JP1
Bensouda, B1
Bruel, H1
Simon, A1
Poinsot, J1
Ickowicz, V1
Degre, S1
Asai, S1
Miyachi, H1
Kobayashi, H1
Hotta, T1
Ando, Y1
Ryan, M1
Baumann, RJ1
Miller, CS1
Baker, C1
Kryzhanovskiĭ, GN1
Abramova, EM1
Abrosimov, IIu1
Shime, H1
Araki, R1
Koide, H1
Miyaji, T1
Shioda, K1
McKee, PJ1
Percy-Robb, I1
Verbiest, HB1
Straver, JS1
Colombo, JP1
van der Vijver, JC1
van Woerkom, TC1
Suzuki, T1
Koizumi, J1
Moroji, T1
Shiraishi, H1
Hori, T1
Baba, A1
Kawai, N1
Tada, K1
Pelzl, G1
Mamoli, B1
Rastogi, P1
Mehrotra, TN1
Agarwala, RK1
Singh, VS1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effectiveness and Safety of Thread Embedding Acupuncture for Drug Resistant Epilepsy: a Randomized Clinical Trial[NCT04673071]60 participants (Anticipated)Interventional2020-11-17Recruiting
A Therapeutic Confirmatory, Open-label, Multi-center, Randomized 2 Parallel Groups, Community-based Trial Studying the Efficacy and Safety of Levetiracetam (1000 to 3000 mg/Day Oral Tablets 250-500 mg b.i.d.) Compared to Sodium Valproate (1000 to 2000 mg/[NCT00175903]Phase 31,701 participants (Actual)Interventional2005-02-28Completed
Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy: A Randomized, add-on Placebo-controlled Clinical Trial[NCT03590197]Phase 4104 participants (Actual)Interventional2018-08-06Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

36 reviews available for valproic acid and Convulsive Generalized Seizure Disorder

ArticleYear
A systematic review of the efficacy of perampanel as treatment for myoclonic seizures and symptomatic myoclonus
    Epileptic disorders : international epilepsy journal with videotape, 2022, 08-01, Volume: 24, Issue:4

    Topics: Anticonvulsants; Epilepsies, Myoclonic; Epilepsy, Generalized; Humans; Immunoglobulin E; Levetiracet

2022
Therapeutic approach to neurological manifestations of Angelman syndrome.
    Expert review of clinical pharmacology, 2022, Volume: 15, Issue:7

    Topics: Angelman Syndrome; Anticonvulsants; Epilepsy; Epilepsy, Generalized; Humans; Valproic Acid

2022
Extreme late onset of genetic generalized epilepsy in older adults and the elderly: A cohort study and literature review.
    Epilepsia open, 2023, Volume: 8, Issue:1

    Topics: Aged; Anticonvulsants; Cohort Studies; Epilepsy, Absence; Epilepsy, Generalized; Female; Humans; Mal

2023
Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis.
    Journal of neurology, 2023, Volume: 270, Issue:10

    Topics: Anticonvulsants; Child; Epilepsy, Generalized; Ethosuximide; Humans; Levetiracetam; Network Meta-Ana

2023
A reappraisal of atypical absence seizures in children and adults: therapeutic implications.
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:17

    Topics: Anticonvulsants; Epilepsy, Generalized; Ethosuximide; Humans; Lamotrigine; Lennox Gastaut Syndrome;

2019
Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective.
    Journal of neurology, 2021, Volume: 268, Issue:8

    Topics: Anticonvulsants; Child; Epilepsy; Epilepsy, Generalized; Female; Humans; Pregnancy; Pregnancy Compli

2021
Genetic/idiopathic generalized epilepsies: Not so good as that!
    Revue neurologique, 2020, Volume: 176, Issue:6

    Topics: Abnormalities, Drug-Induced; Adult; Comorbidity; Contraindications, Drug; Death, Sudden; Epilepsy, G

2020
Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE).
    Seizure, 2021, Volume: 85

    Topics: Animals; Anticonvulsants; Child; Epilepsy, Generalized; Female; Humans; Italy; Phthiraptera; Pregnan

2021
Neuropharmacology of Antiseizure Drugs.
    Neuropsychopharmacology reports, 2021, Volume: 41, Issue:3

    Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Humans; Neuropharmacology; Ph

2021
Anticonvulsant drugs for generalized tonic-clonic epilepsy.
    Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:9

    Topics: Acetamides; Anticonvulsants; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Fructose; Humans

2017
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    The Cochrane database of systematic reviews, 2017, 06-29, Volume: 6

    Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Parti

2017
Lamotrigine versus valproic acid monotherapy for generalised epilepsy: A meta-analysis of comparative studies.
    Seizure, 2017, Volume: 51

    Topics: Anticonvulsants; Epilepsy, Generalized; Female; Humans; Lamotrigine; Male; Triazines; Valproic Acid

2017
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    The Cochrane database of systematic reviews, 2017, 12-15, Volume: 12

    Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Parti

2017
Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses.
    International journal of clinical pharmacy, 2018, Volume: 40, Issue:3

    Topics: Anticonvulsants; Bayes Theorem; Epilepsy, Generalized; Humans; Network Meta-Analysis; Randomized Con

2018
Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.
    The Cochrane database of systematic reviews, 2018, 08-09, Volume: 8

    Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Humans; Phenytoin; Randomized Controlle

2018
[Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Rinsho shinkeigaku = Clinical neurology, 2019, May-28, Volume: 59, Issue:5

    Topics: Aged; Ammonia; Anticonvulsants; Biomarkers; Cardiomyopathies; Carnitine; Consciousness Disorders; Ep

2019
Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures.
    The Cochrane database of systematic reviews, 2013, Aug-23, Issue:8

    Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Phenyto

2013
Pharmacotherapy for tonic-clonic seizures.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:10

    Topics: Acetamides; Anticonvulsants; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Fructose; Humans; Lacosa

2014
Acupuncture for epilepsy.
    The Cochrane database of systematic reviews, 2014, May-07, Issue:5

    Topics: Acupuncture Therapy; Anticonvulsants; Child; Combined Modality Therapy; Drugs, Chinese Herbal; Epile

2014
Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review.
    The Cochrane database of systematic reviews, 2016, Apr-28, Volume: 4

    Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Phenyto

2016
The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Epilepsia, 2009, Volume: 50 Suppl 8

    Topics: Anticonvulsants; Congenital Abnormalities; Delayed-Action Preparations; Drug Design; Epilepsy, Gener

2009
Epilepsy (generalised).
    BMJ clinical evidence, 2010, Jun-22, Volume: 2010

    Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Incidence; Phenytoin; Remis

2010
Epilepsy (generalised).
    BMJ clinical evidence, 2012, Feb-20, Volume: 2012

    Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Incidence; Phenytoin; Remis

2012
SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study.
    Pharmacogenomics, 2012, Volume: 13, Issue:13

    Topics: Adolescent; Adult; Alternative Splicing; Anticonvulsants; Asian People; Child; Cohort Studies; Epile

2012
Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trials.
    Statistics in medicine, 2002, Sep-30, Volume: 21, Issue:18

    Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Anticonvulsants; Child; Child, Preschool;

2002
[Other generalized epilepsies not defined above].
    Ryoikibetsu shokogun shirizu, 2002, Issue:37 Pt 6

    Topics: Diagnosis, Differential; Epilepsy, Generalized; Humans; Phenobarbital; Prognosis; Syndrome; Valproic

2002
Chronic management of seizures in the syndromes of idiopathic generalized epilepsy.
    Epilepsia, 2003, Volume: 44 Suppl 2

    Topics: Adult; Anticonvulsants; Child; Clinical Trials as Topic; Epilepsy, Generalized; Fructose; Humans; La

2003
Acute management of seizures in the syndromes of idiopathic generalized epilepsies.
    Epilepsia, 2003, Volume: 44 Suppl 2

    Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Clonazepam; Comorbidity; Drug Administration Sche

2003
Management guidelines for children with idiopathic generalized epilepsy.
    Epilepsia, 2005, Volume: 46 Suppl 9

    Topics: Adolescent; Anticonvulsants; Child; Electroencephalography; Epilepsy, Absence; Epilepsy, Generalized

2005
Practical management issues for idiopathic generalized epilepsies.
    Epilepsia, 2005, Volume: 46 Suppl 9

    Topics: Age Factors; Age of Onset; Anticonvulsants; Electric Stimulation Therapy; Epilepsy, Generalized; Hum

2005
New statistical method for analyzing time to first seizure: example using data comparing carbamazepine and valproate monotherapy.
    Epilepsia, 2007, Volume: 48, Issue:6

    Topics: Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; Data Interpretation, Statistical; Epileps

2007
Antiepileptic drug mechanisms of action.
    Epilepsia, 1993, Volume: 34 Suppl 5

    Topics: Acetates; Action Potentials; Amines; Anticonvulsants; Calcium Channels; Cyclohexanecarboxylic Acids;

1993
[Clinical results with sodium valproate in childhood and in adolescence].
    Praxis, 1994, Oct-04, Volume: 83, Issue:40

    Topics: Adolescent; Child; Child, Preschool; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Generalized;

1994
Clinical use of drugs useful in the treatment of atonic seizures.
    Advances in neurology, 1995, Volume: 67

    Topics: Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Clobazam; Epilepsy, Genera

1995
The management of refractory idiopathic epilepsies.
    Epilepsia, 2001, Volume: 42 Suppl 3

    Topics: Adolescent; Anticonvulsants; Child; Clinical Protocols; Drug Administration Schedule; Drug Therapy,

2001
Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
    The Cochrane database of systematic reviews, 2001, Issue:4

    Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Humans; Phenytoin; Randomized Controlle

2001

Trials

32 trials available for valproic acid and Convulsive Generalized Seizure Disorder

ArticleYear
Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
    Epilepsy research, 2019, Volume: 157

    Topics: Adolescent; Adult; Anticonvulsants; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Myoc

2019
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
    Lancet (London, England), 2021, 04-10, Volume: 397, Issue:10282

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Child, Preschool; Cost-Benefit A

2021
Time to 12-month remission and treatment failure for generalised and unclassified epilepsy.
    Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:6

    Topics: Adolescent; Adult; Anticonvulsants; Child; Electroencephalography; Epilepsy, Generalized; Female; Fr

2014
Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
    Epilepsy research, 2015, Volume: 114

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Electroencephalography; Epileps

2015
Monotherapy of epilepsy in women: psychiatric and neuroendocrine aspects.
    Neuroscience and behavioral physiology, 2010, Volume: 40, Issue:2

    Topics: Adult; Anticonvulsants; Barbiturates; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Est

2010
[Efficacy and safety of the combined therapy of valproic acid and lamotrigine for epileptics].
    Zhonghua yi xue za zhi, 2012, May-08, Volume: 92, Issue:17

    Topics: Child; Child, Preschool; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, Absence

2012
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:10

    Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug

2013
SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study.
    Pharmacogenomics, 2012, Volume: 13, Issue:13

    Topics: Adolescent; Adult; Alternative Splicing; Anticonvulsants; Asian People; Child; Cohort Studies; Epile

2012
Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures.
    Epilepsy research, 2002, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Analysis of Variance; Asthenia; Child; Cross-Over Studies; Delayed-Action Prepara

2002
Long-term neuropsychological follow-up and nosological considerations in five patients with continuous spikes and waves during slow sleep.
    Epileptic disorders : international epilepsy journal with videotape, 2002, Volume: 4, Issue:4

    Topics: Adrenocorticotropic Hormone; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Child; Child, Pr

2002
[Clinical efficacy and tolerability of topamax in combined therapy of epilepsy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2003, Volume: 103, Issue:3

    Topics: Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Drug

2003
Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy.
    Neurology, 2003, Oct-14, Volume: 61, Issue:7

    Topics: Adolescent; Adult; Anticonvulsants; Aspartic Acid; Carnosine; Epilepsy, Generalized; Female; Frontal

2003
Add-on melatonin improves sleep behavior in children with epilepsy: randomized, double-blind, placebo-controlled trial.
    Journal of child neurology, 2005, Volume: 20, Issue:2

    Topics: Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Epilepsies

2005
[Mexidol in treatment of children with generalized epilepsy and febrile seizures].
    Georgian medical news, 2005, Issue:122

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Electroencephalogra

2005
[Efficacy of keppra in combined therapy in pharmacoresistant adult epilepsy patients].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2005, Volume: 105, Issue:7

    Topics: Adult; Anticonvulsants; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Ep

2005
The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
    Seizure, 2005, Volume: 14, Issue:8

    Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Demography; Epilepsies, Partial; Epilepsy, Genera

2005
Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics.
    European journal of clinical pharmacology, 2006, Volume: 62, Issue:10

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Chronic Disease; Cross-Over Studies; Data Inte

2006
Evaluation of renal tubular function in children taking anti-epileptic treatment.
    Nephrology (Carlton, Vic.), 2006, Volume: 11, Issue:6

    Topics: Acetylglucosaminidase; Anticonvulsants; Biomarkers; Blood Urea Nitrogen; Carbamazepine; Child; Child

2006
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
    Lancet (London, England), 2007, Mar-24, Volume: 369, Issue:9566

    Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Cost-Benefit Analysis; Epilepsy, Genera

2007
Sodium valproate and mental processes in newly referred epileptic patients. A computerized EEG study.
    Neuropsychobiology, 1995, Volume: 31, Issue:4

    Topics: Adolescent; Adult; Child; Cognition; Electroencephalography; Epilepsy, Generalized; Female; Fixation

1995
Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.
    Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:1

    Topics: Adolescent; Adult; Aged; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female;

1995
A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group.
    Developmental medicine and child neurology, 1995, Volume: 37, Issue:2

    Topics: Administration, Oral; Adolescent; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized;

1995
A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:6

    Topics: Administration, Oral; Adult; Ambulatory Care Facilities; Carbamazepine; Clinical Protocols; Drug Eru

1994
Felbamate in the treatment of refractory partial-onset seizures.
    Epilepsia, 1993, Volume: 34 Suppl 7

    Topics: Adult; Anticonvulsants; Child; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial;

1993
Valproate versus carbamazepine for seizures.
    The New England journal of medicine, 1993, Jan-21, Volume: 328, Issue:3

    Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Complex Partial; Epile

1993
A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.
    Epilepsy research, 1997, Volume: 26, Issue:3

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Double-Bl

1997
Weight gain with valproate or carbamazepine--a reappraisal.
    Seizure, 1997, Volume: 6, Issue:2

    Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross-Over Studies; Dose-Respon

1997
Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Pediatric neurology, 1997, Volume: 16, Issue:3

    Topics: Adolescent; Anticonvulsants; Benzodiazepines; Child; Child, Preschool; Drug Therapy, Combination; Ep

1997
Weight gain associated with valproate in childhood.
    Pediatric neurology, 2000, Volume: 22, Issue:5

    Topics: Adolescent; Anticonvulsants; Blood Glucose; Carnitine; Child; Child, Preschool; Drug Therapy, Combin

2000
[Gabitril as an additive drug in therapy of intractable epileptic seizures in children].
    Neurologia i neurochirurgia polska, 2000, Volume: 34 Suppl 7

    Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Drug Therapy, Combi

2000
[A single daily dose with valproic acid. A pharmacodynamic and clinical study].
    Wiener klinische Wochenschrift, 1992, Volume: 104, Issue:10

    Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Com

1992
Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy.
    The Journal of the Association of Physicians of India, 1991, Volume: 39, Issue:8

    Topics: Adolescent; Adult; Child; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Male; Middle A

1991

Other Studies

176 other studies available for valproic acid and Convulsive Generalized Seizure Disorder

ArticleYear
Evaluation of optical coherence tomography findings in adolescents with genetic generalized epilepsy.
    European journal of ophthalmology, 2022, Volume: 32, Issue:6

    Topics: Adolescent; Epilepsy; Epilepsy, Generalized; Humans; Retina; Tomography, Optical Coherence; Valproic

2022
Treatment outcomes in women with idiopathic generalized epilepsy.
    Acta neurologica Scandinavica, 2022, Volume: 145, Issue:4

    Topics: Adult; Anticonvulsants; Child; Epilepsy, Generalized; Female; Humans; Male; Retrospective Studies; T

2022
Effect of Chronic Valproic Acid Use on Anterior Cerebral Blood Flow of Children with Idiopathic Generalized Epilepsy.
    Acta neurologica Taiwanica, 2022, Mar-25, Volume: 31(2)

    Topics: Anticonvulsants; Blood Flow Velocity; Cerebrovascular Circulation; Child; Child, Preschool; Epilepsy

2022
Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
    Epilepsy & behavior : E&B, 2022, Volume: 130

    Topics: Aged; Anticonvulsants; Benzodiazepines; Carbamazepine; Drug Prescriptions; Epilepsy; Epilepsy, Gener

2022
ARHGEF9 gene variant leads to developmental and epileptic encephalopathy: Genotypic phenotype analysis and treatment exploration.
    Molecular genetics & genomic medicine, 2022, Volume: 10, Issue:7

    Topics: Epilepsy; Epilepsy, Generalized; Humans; Levetiracetam; Phenotype; Retrospective Studies; Rho Guanin

2022
Seizure control in mono- and combination therapy in a cohort of patients with Idiopathic Generalized Epilepsy.
    Scientific reports, 2022, 07-19, Volume: 12, Issue:1

    Topics: Adolescent; Anticonvulsants; Drug Therapy, Combination; Epilepsy, Generalized; Female; Humans; Immun

2022
Vestibular function in children with generalized epilepsy and treated with valproate.
    Expert review of clinical pharmacology, 2022, Volume: 15, Issue:12

    Topics: Child; Cross-Sectional Studies; Epilepsy, Generalized; Female; Humans; Male; Valproic Acid; Vestibul

2022
Efficacy of antiseizure medication in a mouse model of HCN1 developmental and epileptic encephalopathy.
    Epilepsia, 2023, Volume: 64, Issue:1

    Topics: Animals; Anticonvulsants; Epilepsy; Epilepsy, Generalized; Hyperpolarization-Activated Cyclic Nucleo

2023
Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study.
    Neurology, 2023, 04-04, Volume: 100, Issue:14

    Topics: Anticonvulsants; Drug Resistant Epilepsy; Epilepsy, Generalized; Glioma; Humans; Retrospective Studi

2023
Minimum effective sodium valproate dose in genetic generalized epilepsies.
    Seizure, 2023, Volume: 108

    Topics: Anticonvulsants; Drug-Related Side Effects and Adverse Reactions; Epilepsy, Generalized; Humans; Ret

2023
Arginase deficiency-An unheralded cause of developmental epileptic encephalopathy.
    Epileptic disorders : international epilepsy journal with videotape, 2023, Volume: 25, Issue:4

    Topics: Child; Epilepsy; Epilepsy, Generalized; Humans; Hyperammonemia; Hyperargininemia; Valproic Acid

2023
Real-world practices for the care of women with epilepsy during pregnancy: A Canadian perspective.
    Epilepsy & behavior : E&B, 2023, Volume: 148

    Topics: Adult; Anticonvulsants; Canada; Epilepsy; Epilepsy, Generalized; Female; Humans; Pregnancy; Pregnanc

2023
Idiopathic generalized epilepsy with phantom absences, absence status, and generalized tonic-clonic seizures: A case report.
    Medicine, 2023, Nov-10, Volume: 102, Issue:45

    Topics: Adult; Electroencephalography; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Fem

2023
Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome.
    Epilepsia, 2020, Volume: 61, Issue:1

    Topics: Adolescent; Adult; Anticonvulsants; Drug Substitution; Epilepsy, Generalized; Female; Humans; Retros

2020
Tonic-clonic seizures in idiopathic generalized epilepsies: Prevalence, risk factors, and outcome.
    Acta neurologica Scandinavica, 2020, Volume: 141, Issue:6

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsy, Generalized;

2020
Cortical excitability measured with transcranial magnetic stimulation in children with epilepsy before and after antiepileptic drugs.
    Developmental medicine and child neurology, 2020, Volume: 62, Issue:7

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Cortical Excitability; Electroencephalography;

2020
Treatment of epilepsy in adults: Expert opinion in South Korea.
    Epilepsy & behavior : E&B, 2020, Volume: 105

    Topics: Adult; Aged; Anticonvulsants; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Generalized; Expert

2020
Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study.
    Pharmacogenomics, 2020, Volume: 21, Issue:5

    Topics: Adolescent; Anticonvulsants; Case-Control Studies; Child; Cohort Studies; Epilepsy, Generalized; Eur

2020
Rapid eye movement (REM) sleep and seizure control in idiopathic generalized epilepsy.
    Epilepsy & behavior : E&B, 2020, Volume: 107

    Topics: Adolescent; Adult; Anticonvulsants; Child; Cohort Studies; Egypt; Epilepsy, Generalized; Female; Fol

2020
Valproate impact and sex-dependent seizure remission in patients with idiopathic generalized epilepsy.
    Journal of the neurological sciences, 2020, 08-15, Volume: 415

    Topics: Adolescent; Adult; Anticonvulsants; Epilepsy, Generalized; Female; Humans; Male; Middle Aged; Retros

2020
The clinical spectrum of familial and sporadic idiopathic generalized epilepsy.
    Epilepsy research, 2020, Volume: 165

    Topics: Adolescent; Adult; Anticonvulsants; Epilepsy, Generalized; Female; Genetic Predisposition to Disease

2020
Choosing Anticonvulsant Medications to Manage Status Epilepticus.
    The New England journal of medicine, 2020, 06-25, Volume: 382, Issue:26

    Topics: Adult; Anticonvulsants; Disease Management; Drug Therapy, Combination; Epilepsy, Generalized; Female

2020
[Dynamics of epileptiform activity, efficacy and tolerability of valproic acid in adults and adolescents with newly-diagnosed epilepsy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2020, Volume: 120, Issue:7

    Topics: Adolescent; Adult; Anticonvulsants; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy,

2020
Eight years follow-up of a generalized epilepsy patient with eating-induced late-onset epileptic spasms and atypical absence with myoclonic jerks.
    Brain & development, 2021, Volume: 43, Issue:1

    Topics: Adolescent; China; Clonazepam; Eating; Epilepsy, Generalized; Follow-Up Studies; Humans; Male; Myocl

2021
Patterns and prognostic markers for treatment response in generalized epilepsies.
    Neurology, 2020, 11-03, Volume: 95, Issue:18

    Topics: Adolescent; Adult; Anticonvulsants; Biomarkers; Drug Resistance; Epilepsy, Generalized; Humans; Lamo

2020
Persistent treatment resistance in genetic generalized epilepsy: A long-term outcome study in a tertiary epilepsy center.
    Epilepsia, 2020, Volume: 61, Issue:11

    Topics: Adult; Anticonvulsants; Cohort Studies; Drug Resistant Epilepsy; Electroencephalography; Epilepsy, G

2020
Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy.
    Epilepsy research, 2021, Volume: 170

    Topics: Adult; Anticonvulsants; Epilepsy, Generalized; Humans; Lamotrigine; Levetiracetam; Myoclonic Epileps

2021
Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women.
    Acta neurologica Scandinavica, 2021, Volume: 143, Issue:4

    Topics: Adolescent; Adult; Anticonvulsants; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Leveti

2021
Unmasking the entity of 'drug-resistant' perioral myoclonia with absences: the twitches, darts and domes!
    Epileptic disorders : international epilepsy journal with videotape, 2021, Apr-01, Volume: 23, Issue:2

    Topics: Adolescent; Child; Electroencephalography; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy, Abs

2021
Our reasons for converting to valproic acid treatment in female patients with genetic generalized epilepsy: a retrospective, single-centre study.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:1

    Topics: Adolescent; Anticonvulsants; Child; Electroencephalography; Epilepsy, Generalized; Female; Humans; R

2022
Predictors of successful valproate withdrawal in women with epilepsy.
    Epilepsy & behavior : E&B, 2021, Volume: 119

    Topics: Anticonvulsants; Epilepsy; Epilepsy, Generalized; Female; Humans; Levetiracetam; Valproic Acid

2021
Valproic acid use in fertile women with genetic generalized epilepsies.
    Acta neurologica Scandinavica, 2021, Volume: 144, Issue:3

    Topics: Anticonvulsants; Epilepsy; Epilepsy, Generalized; Female; Humans; Infant, Newborn; Male; Retrospecti

2021
SLC13A5-related epileptic encephalopathy successfully treated with valproate and acetazolamide.
    Seizure, 2021, Volume: 91

    Topics: Acetazolamide; Brain Diseases; Epilepsy, Generalized; Humans; Symporters; Valproic Acid

2021
Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Seizure, 2021, Volume: 91

    Topics: Anticonvulsants; Child; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Infant; Levetiracetam

2021
Resting-state functional connectivity changes due to acute and short-term valproic acid administration in the baboon model of GGE.
    NeuroImage. Clinical, 2017, Volume: 16

    Topics: Animals; Brain; Brain Mapping; Disease Models, Animal; Epilepsy, Generalized; Female; Magnetic Reson

2017
Defining the phenotypic spectrum of SLC6A1 mutations.
    Epilepsia, 2018, Volume: 59, Issue:2

    Topics: Adolescent; Adult; Anticonvulsants; Ataxia; Child; Child, Preschool; Cohort Studies; Electroencephal

2018
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.
    JAMA neurology, 2019, 07-01, Volume: 76, Issue:7

    Topics: Adolescent; Adult; Anticonvulsants; Anxiety Disorders; Comorbidity; Dissociative Disorders; Epilepsi

2019
D. Olsen and A. Baftiu respond.
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2019, 04-09, Volume: 139, Issue:7

    Topics: Epilepsy, Generalized; Female; Humans; Valproic Acid

2019
Continued importance of valproate for women with generalised epilepsy.
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2019, 04-09, Volume: 139, Issue:7

    Topics: Anticonvulsants; Epilepsy, Generalized; Female; Humans; Pregnancy; Valproic Acid

2019
Blood levels of cytokines in children with idiopathic partial and generalized epilepsy.
    Seizure, 2013, Volume: 22, Issue:7

    Topics: Anticonvulsants; Chi-Square Distribution; Child; Cytokines; Disease Progression; Electroencephalogra

2013
Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats.
    Epilepsy research, 2013, Volume: 106, Issue:1-2

    Topics: Aging; Allylisopropylacetamide; Amides; Animals; Anticonvulsants; Convulsants; Epilepsy, Generalized

2013
Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital.
    BMC research notes, 2013, Nov-18, Volume: 6

    Topics: Adolescent; Adult; Anticonvulsants; Bangladesh; Carbamazepine; Child; Drug Combinations; Epilepsies,

2013
Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
    Acta neurologica Scandinavica, 2014, Volume: 129, Issue:5

    Topics: Adult; Anticonvulsants; Epilepsy, Absence; Epilepsy, Generalized; Female; Follow-Up Studies; Humans;

2014
QPEEG analysis of the effects of sodium valproate on adult Chinese patients with generalized tonic-clonic seizures.
    Metabolic brain disease, 2014, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Brain; China; Electroencephalography; Epilepsy, Generalized; Female; Humans; Male

2014
Evidence for increased visual gamma responses in photosensitive epilepsy.
    Epilepsy research, 2014, Volume: 108, Issue:6

    Topics: Adolescent; Adult; Anticonvulsants; Brain; Child; Epilepsy, Generalized; Epilepsy, Reflex; Evoked Po

2014
Serum, urine, and saliva levels of ghrelin and obestatin pre- and post-treatment in pediatric epilepsy.
    Pediatric neurology, 2014, Volume: 51, Issue:3

    Topics: Anticonvulsants; Blood Chemical Analysis; Child; Child, Preschool; Epilepsy, Generalized; Female; Gh

2014
Withholding the choice of sodium valproate to young women with generalised epilepsy: Are we causing more harm than good?
    Seizure, 2015, Volume: 24

    Topics: Adolescent; Anticonvulsants; Epilepsy, Generalized; Female; Humans; Treatment Outcome; Valproic Acid

2015
Insulin resistance in patients on valproic acid: relation to adiponectin.
    Acta neurologica Scandinavica, 2015, Volume: 131, Issue:3

    Topics: Adiponectin; Adolescent; Anticonvulsants; Blood Glucose; Child; Epilepsy, Generalized; Female; Human

2015
Atherosclerotic effects of long-term old and new antiepileptic drugs monotherapy: a cross-sectional comparative study.
    Journal of child neurology, 2015, Volume: 30, Issue:4

    Topics: Adolescent; Anticonvulsants; Carbamazepine; Carotid Arteries; Carotid Intima-Media Thickness; Cross-

2015
Concentration of Il-1β, Il-2, Il-6, TNFα in the blood serum in children with generalized epilepsy treated by valproate.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:6

    Topics: Anticonvulsants; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epilepsy, Generalized;

2014
Valproate treatment normalizes EEG functional connectivity in successfully treated idiopathic generalized epilepsy patients.
    Epilepsy research, 2014, Volume: 108, Issue:10

    Topics: Adolescent; Adult; Alpha Rhythm; Anticonvulsants; Brain; Brain Mapping; Child; Delta Rhythm; Electro

2014
The dilemma of treating young women with generalized epilepsy with sodium valproate and how to get out of it.
    Seizure, 2015, Volume: 24

    Topics: Anticonvulsants; Epilepsy, Generalized; Female; Humans; Valproic Acid; Young Adult

2015
Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy.
    Epilepsia, 2015, Volume: 56, Issue:1

    Topics: Animals; Anticonvulsants; Brain; Brain Waves; Carbamazepine; Dibenzazepines; Disease Models, Animal;

2015
A child with ictal vocalizations and generalized epilepsy.
    Epileptic disorders : international epilepsy journal with videotape, 2015, Volume: 17, Issue:1

    Topics: Adolescent; Anticonvulsants; Electroencephalography; Epilepsy, Generalized; Epilepsy, Tonic-Clonic;

2015
[Case of combination of Beckwith-Wiedemann syndrome with West syndrome].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 2014, Issue:9-10

    Topics: Anticonvulsants; Beckwith-Wiedemann Syndrome; Child; Clonazepam; Electroencephalography; Epilepsy, G

2014
1-Triacontanol cerotate; isolated from Marsilea quadrifolia Linn. ameliorates reactive oxidative damage in the frontal cortex and hippocampus of chronic epileptic rats.
    Journal of ethnopharmacology, 2015, Aug-22, Volume: 172

    Topics: Animals; Chronic Disease; Dose-Response Relationship, Drug; Epilepsy, Generalized; Fatty Alcohols; F

2015
[Hyperekplexia associated to precocious puberty].
    Revista de neurologia, 2015, Aug-16, Volume: 61, Issue:4

    Topics: Anticonvulsants; Benzodiazepines; Cerebral Palsy; Child; Clobazam; Drug Therapy, Combination; Electr

2015
Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies.
    Epilepsia, 2017, Volume: 58, Issue:4

    Topics: Adult; Anticonvulsants; Cohort Studies; Delta Rhythm; Demography; Drug Resistant Epilepsy; Electroen

2017
Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases?
    Epilepsy research, 2008, Volume: 81, Issue:2-3

    Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy, Genera

2008
Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Epilepsia, 2009, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationshi

2009
Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.
    Epilepsia, 2009, Volume: 50, Issue:11

    Topics: Adolescent; Adult; Angelman Syndrome; Anticonvulsants; Child; Child, Preschool; Clonazepam; Comorbid

2009
Once daily monotherapy with prolonged-release valproate minitablets given in the evening--a chronopharmacological study.
    International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Chronobiology Phenomena; Delayed-Action Prepa

2009
Chitosan may decrease serum valproate and increase the risk of seizure reappearance.
    BMJ (Clinical research ed.), 2009, Sep-24, Volume: 339

    Topics: Adult; Anti-Obesity Agents; Anticonvulsants; Chitosan; Dietary Supplements; Drug Interactions; Epile

2009
The usefulness of olfactory bulb kindling as a model for evaluation of antiepileptics.
    Epilepsia, 2010, Volume: 51, Issue:3

    Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Disease Models, Animal; Electri

2010
Valproate in children with newly diagnosed idiopathic generalized epilepsy.
    Acta neurologica Scandinavica, 2010, Volume: 121, Issue:3

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Drug; Electroencep

2010
Reversible rapidly progressive dementia with parkinsonism induced by valproate in a patient with systemic lupus erythematosus.
    Journal of the American Geriatrics Society, 2010, Volume: 58, Issue:4

    Topics: Aged; Anticonvulsants; Dementia; Diagnosis, Differential; Disease Progression; Epilepsy, Generalized

2010
Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats.
    Seizure, 2010, Volume: 19, Issue:5

    Topics: Animals; Anticonvulsants; Convulsants; Dose-Response Relationship, Drug; Electroshock; Epilepsy, Gen

2010
[Valproate for treatment of women with epilepsy: recommendations of the German Society for Epileptology].
    Der Nervenarzt, 2010, Volume: 81, Issue:6

    Topics: Abnormalities, Drug-Induced; Anticonvulsants; Dose-Response Relationship, Drug; Drug Therapy, Combin

2010
[Seizure aggravation by valproate in primary generalized epilepsy].
    Der Nervenarzt, 2011, Volume: 82, Issue:2

    Topics: Adolescent; Anticonvulsants; Epilepsy, Generalized; Humans; Male; Seizures; Valproic Acid

2011
Rheumatoid leptomeningitis: radiological alteration of cerebral hypoperfusion and subarachnoid lesions.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:17

    Topics: Affective Symptoms; Anticonvulsants; Arthritis, Rheumatoid; Cerebrovascular Circulation; Diffusion M

2010
Thalamofrontal neurodevelopment in new-onset pediatric idiopathic generalized epilepsy.
    Neurology, 2011, Jan-04, Volume: 76, Issue:1

    Topics: Adolescent; Analysis of Variance; Anticonvulsants; Child; Epilepsy, Generalized; Female; Frontal Lob

2011
Valproate reduces spontaneous generalized spikes and waves but not photoparoxysmal reactions in patients with idiopathic generalized epilepsies.
    Epilepsia, 2011, Volume: 52, Issue:7

    Topics: Adolescent; Anticonvulsants; Brain; Child; Electroencephalography; Epilepsy, Generalized; Female; Hu

2011
Association of genetic variants in six candidate genes with valproic acid therapy optimization.
    Pharmacogenomics, 2011, Volume: 12, Issue:8

    Topics: Adult; Alleles; Anticonvulsants; DNA; Epilepsy; Epilepsy, Generalized; Female; Gene Frequency; Genet

2011
Thyroid hormone levels in children receiving carbamazepine or valproate.
    Pediatric neurology, 2011, Volume: 45, Issue:3

    Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross-Sectional Studies; Dose-Response Rela

2011
Atonic variant of benign childhood epilepsy with centrotemporal spikes (atonic-BECTS): a distinct electro-clinical syndrome.
    Brain & development, 2012, Volume: 34, Issue:6

    Topics: Age of Onset; Anticonvulsants; Child, Preschool; Electroencephalography; Epilepsy, Generalized; Epil

2012
Myoclonus precipitated by oral suspension of oxcarbazepine in idiopathic generalized epilepsy.
    International journal of clinical pharmacology and therapeutics, 2012, Volume: 50, Issue:4

    Topics: Administration, Oral; Anticonvulsants; Carbamazepine; Drug Substitution; Electroencephalography; Epi

2012
Confounding diagnoses in the neurodevelopmental disabilities population: a child with hearing loss, absence epilepsy, and attention-deficit hyperactivity disorder (ADHD).
    Journal of child neurology, 2013, Volume: 28, Issue:5

    Topics: Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Audiometry, Pure-Tone; Central Nervo

2013
[Complex therapy of idiopathic forms of epilepsy with small doses of valproates and levetiracetam].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:6 Pt 2

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy, Absence;

2012
[Idiopathic generalized epilepsy in young women: choise of treatment strategy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:6 Pt 2

    Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy, Generalized; Fe

2012
Comparison of triphasic waves and epileptic discharges in one patient with genetic epilepsy.
    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, 2012, Volume: 29, Issue:5

    Topics: Anticonvulsants; Brain; Brain Mapping; Brain Waves; Diagnosis, Differential; Electroencephalography;

2012
The problem of non-superiority: what do we know after KOMET?
    Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:10

    Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Levetira

2013
[Reversible encephalopathy caused by valproic acid in an adolescent with idiopathic generalised epilepsy].
    Revista de neurologia, 2012, Dec-01, Volume: 55, Issue:11

    Topics: Adolescent; Anticonvulsants; Brain Diseases; Epilepsy, Generalized; Humans; Male; Valproic Acid

2012
Reduced default mode network connectivity in treatment-resistant idiopathic generalized epilepsy.
    Epilepsia, 2013, Volume: 54, Issue:3

    Topics: Adolescent; Adult; Down-Regulation; Epilepsy, Generalized; Female; Humans; Male; Middle Aged; Nerve

2013
The relationship between the localization of the generalized spike and wave discharge generators and the response to valproate.
    Epilepsia, 2013, Volume: 54, Issue:3

    Topics: Action Potentials; Adolescent; Adult; Anticonvulsants; Electroencephalography; Epilepsy, Generalized

2013
Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy.
    Epilepsia, 2013, Volume: 54, Issue:2

    Topics: Adult; Age of Onset; Anticonvulsants; Calcium-Binding Proteins; Case-Control Studies; Cell Adhesion

2013
Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.
    Neurology, 2013, Jan-22, Volume: 80, Issue:4

    Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Drug Therapy, Combination; Epilepsy, Generalize

2013
Mild generalized epilepsy and developmental disorder associated with large inv dup(15).
    Epilepsia, 2002, Volume: 43, Issue:9

    Topics: Adult; Age of Onset; Angelman Syndrome; Anticonvulsants; Chromosome Aberrations; Chromosome Inversio

2002
Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Neuropediatrics, 2002, Volume: 33, Issue:4

    Topics: Adolescent; Adult; Blood Coagulation Disorders; Child; Child, Preschool; Epilepsies, Partial; Epilep

2002
[Use of convulex in patients with epilepsy with and without affective disorders].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2002, Volume: 102, Issue:9

    Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Child; Epilepsies, Partial; Epilepsy; Epilepsy, Gen

2002
Non convulsive status epilepticus after replacement of valproate with lamotrigine.
    Journal of neurology, 2002, Volume: 249, Issue:10

    Topics: Adult; Aged; Anticoagulants; Benzodiazepines; Electroencephalography; Epilepsy, Generalized; Female;

2002
Near reflex accommodation spasm: unusual presentation of generalized photosensitive epilepsy.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2002, Volume: 9, Issue:5

    Topics: Accommodation, Ocular; Anticonvulsants; Child; Electroencephalography; Epilepsy, Generalized; Female

2002
[GEFS + syndrome: phenotypic variations from the newborn to the adult in a large French pedigree].
    Revue neurologique, 2003, Volume: 159, Issue:2

    Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Epilepsy, Gener

2003
Favorable outcome of epileptic blindness in children.
    Journal of child neurology, 2003, Volume: 18, Issue:1

    Topics: Acute Disease; Adolescent; Anticonvulsants; Blindness, Cortical; Carbamazepine; Child; Electroenceph

2003
Neurotoxicity following addition of intravenous valproate to lamotrigine therapy.
    Neurology, 2003, Jun-24, Volume: 60, Issue:12

    Topics: Administration, Oral; Adult; Ammonia; Anticonvulsants; Confusion; Drug Interactions; Drug Therapy, C

2003
Rapid infusion of sodium valproate in acutely ill children.
    Pediatric neurology, 2003, Volume: 28, Issue:4

    Topics: Acute Disease; Adolescent; Anticonvulsants; Child; Child, Preschool; Dose-Response Relationship, Dru

2003
[The use of depakene and depakene-chrono in idiopathic generalized epilepsy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2003, Volume: 103, Issue:9

    Topics: Adolescent; Adult; Anticonvulsants; Drug Administration Schedule; Epilepsies, Myoclonic; Epilepsy, G

2003
Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Pharmacology, 2004, Volume: 70, Issue:2

    Topics: Anticonvulsants; Chemical and Drug Induced Liver Injury; Child, Preschool; Epilepsy, Generalized; Hu

2004
Factor XIII deficiency associated with valproate treatment.
    Epilepsia, 2004, Volume: 45, Issue:2

    Topics: Anticonvulsants; Child; Epilepsies, Myoclonic; Epilepsy, Absence; Epilepsy, Generalized; Epistaxis;

2004
Epilepsy versus antiepileptic drugs and gonadal function in men.
    Neurology, 2004, Jan-27, Volume: 62, Issue:2

    Topics: Androstenedione; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Humans;

2004
Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy.
    Neurology, 2004, Jan-27, Volume: 62, Issue:2

    Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Epileps

2004
Effect of epilepsy and antiepileptic drugs on male reproductive health.
    Neurology, 2004, Jan-27, Volume: 62, Issue:2

    Topics: Adult; Androstenedione; Anticonvulsants; Carbamazepine; Dehydroepiandrosterone Sulfate; Epilepsies,

2004
Primary generalized epilepsy during infancy and early childhood.
    Journal of child neurology, 2004, Volume: 19, Issue:3

    Topics: Anticonvulsants; Child, Preschool; Drug Therapy, Combination; Electroencephalography; Epilepsy, Gene

2004
Non-equivalence of bioavailability between generic and branded form of sodium valproate.
    Neurology India, 2004, Volume: 52, Issue:3

    Topics: Adult; Anticonvulsants; Biological Availability; Drugs, Generic; Epilepsy, Generalized; Humans; Inte

2004
[Efficacy and safety of antiepileptic therapy in children (a comparative analysis of valproates and barbiturates)].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2004, Volume: 104, Issue:8

    Topics: Adolescent; Age Factors; Anticonvulsants; Barbiturates; Child; Child, Preschool; Electroencephalogra

2004
The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate.
    Medical hypotheses, 2005, Volume: 64, Issue:2

    Topics: Calcium; Central Nervous System; Epilepsy, Generalized; Humans; Nerve Growth Factors; Protein Kinase

2005
Initiation of treatment and selection of antiepileptic drugs in childhood epilepsy.
    Epilepsia, 2004, Volume: 45 Suppl 8

    Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy;

2004
Influence of ethanol on the threshold for electroshock-induced seizures and electrically-evoked hippocampal afterdischarges.
    Journal of neural transmission (Vienna, Austria : 1996), 2005, Volume: 112, Issue:9

    Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Drug Synergism; Electric Stimulatio

2005
Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Epileptic disorders : international epilepsy journal with videotape, 2004, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Anticonvulsants; Child; Dose-Response Relationship, Drug; Drug Interactions; Drug

2004
Lamotrigine-induced rash--worth a rechallenge.
    Acta neurologica Scandinavica, 2005, Volume: 111, Issue:3

    Topics: Anticonvulsants; Epilepsy, Generalized; Exanthema; Humans; Lamotrigine; Retrospective Studies; Risk

2005
Prolonged postictal stupor: nonconvulsive status epilepticus, medication effect, or postictal state?
    Epilepsy & behavior : E&B, 2005, Volume: 7, Issue:3

    Topics: Adult; Anticonvulsants; Benzodiazepines; Coma; Diagnosis, Differential; Electroencephalography; Epil

2005
[Anticonvulsive pharmacotherapy may aggravate epilepsy course].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2005, Volume: 105, Issue:10

    Topics: Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Electroencephalography; Epilepsy;

2005
Distribution of spatial complexity of EEG in idiopathic generalized epilepsy and its change after chronic valproate therapy.
    Brain topography, 2005,Winter, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Anticonvulsants; Chronic Disease; Data Interpretation, Statistical; Dose-Response

2005
The effect of valproate on silent period and corticomotor excitability.
    Epileptic disorders : international epilepsy journal with videotape, 2006, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy, Generalized; Evoked

2006
Myoclonic-astatic epilepsy in a child with Sturge-Weber syndrome.
    Pediatric neurology, 2007, Volume: 36, Issue:2

    Topics: Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epilepsies, Myoclonic; Epilepsies, Pa

2007
Valproate selectively reduces EEG activity in anterior parts of the cortex in patients with idiopathic generalized epilepsy. A low resolution electromagnetic tomography (LORETA) study.
    Epilepsy research, 2007, Volume: 75, Issue:2-3

    Topics: Adolescent; Adult; Anticonvulsants; Cerebral Cortex; Child; Data Interpretation, Statistical; Delta

2007
Valproate decreases EEG synchronization in a use-dependent manner in idiopathic generalized epilepsy.
    Seizure, 2008, Volume: 17, Issue:3

    Topics: Anticonvulsants; Cortical Synchronization; Electroencephalography; Epilepsy, Generalized; Humans; Va

2008
Acute hemorrhagic pancreatitis due to the use of valproic acid in a child.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2008, Volume: 12, Issue:2

    Topics: Acute Disease; Anticonvulsants; Child; Epilepsy, Generalized; Hemorrhage; Humans; Intellectual Disab

2008
Absence status epilepsy: delineation of a distinct idiopathic generalized epilepsy syndrome.
    Epilepsia, 2008, Volume: 49, Issue:4

    Topics: Adolescent; Adult; Age Factors; Age of Onset; Aged; Anticonvulsants; Benzodiazepines; Child; Comorbi

2008
Increased oxidative stress in epileptic children treated with valproic acid.
    Epilepsy research, 2008, Volume: 78, Issue:2-3

    Topics: Anthropometry; Anticonvulsants; Antioxidants; Blood Chemical Analysis; Blood Glucose; Child; Epileps

2008
Congenital gingival hyperplasia in a neonate with foetal valproate syndrome.
    Neuropediatrics, 2007, Volume: 38, Issue:5

    Topics: Adult; Anticonvulsants; Apgar Score; Craniofacial Abnormalities; Dose-Response Relationship, Drug; E

2007
[Visual auras in idiopathic generalized epilepsy].
    Revue neurologique, 2008, Volume: 164, Issue:3

    Topics: Adolescent; Anticonvulsants; Behavior; Electroencephalography; Epilepsy; Epilepsy, Generalized; Epil

2008
[The effect of valproic acid monotherapy on behavior and cognitive performance of children with idiopathic generalized epilepsy].
    Zeitschrift fur Kinder- und Jugendpsychiatrie, 1995, Volume: 23, Issue:3

    Topics: Adolescent; Anticonvulsants; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Elec

1995
Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 1995, Volume: 11, Issue:8

    Topics: Anticonvulsants; Auditory Pathways; Brain Stem; Carbamazepine; Child; Child, Preschool; Epilepsies,

1995
Valproic toxicity with fluoxetine therapy.
    Missouri medicine, 1995, Volume: 92, Issue:6

    Topics: Adolescent; Age of Onset; Depressive Disorder; Dose-Response Relationship, Drug; Epilepsy, Generaliz

1995
Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous ("controlled release") administration in a model of generalized seizures in rats.
    Epilepsia, 1995, Volume: 36, Issue:9

    Topics: Animals; Delayed-Action Preparations; Epilepsy, Generalized; Female; Infusions, Intravenous; Pentyle

1995
Carbamazepine-induced Stevens-Johnson syndrome in a child.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:5

    Topics: Anti-Bacterial Agents; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy, Generalized; Human

1995
[The pharmacokinetic optimization of depakin in children with epilepsy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1994, Volume: 94, Issue:6

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Ep

1994
Lamotrigine versus carbamazepine in epilepsy.
    Lancet (London, England), 1995, May-20, Volume: 345, Issue:8960

    Topics: Adult; Anticonvulsants; Clonazepam; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Lamotrigi

1995
Effects of antiepileptic drugs on EEG background activity in children with epilepsy: initial phase of therapy.
    Clinical EEG (electroencephalography), 1995, Volume: 26, Issue:2

    Topics: Alpha Rhythm; Anticonvulsants; Carbamazepine; Child; Delta Rhythm; Electroencephalography; Epilepsie

1995
Lamotrigine as an add-on drug in typical absence seizures.
    Acta neurologica Scandinavica, 1995, Volume: 91, Issue:3

    Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy, Ge

1995
Discontinuation of antiepileptic drug in childhood epilepsy: evaluation of the differences between epileptic syndromes.
    The Japanese journal of psychiatry and neurology, 1994, Volume: 48, Issue:2

    Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Administration Schedule; E

1994
A comparative study of serum F protein and other liver function tests as an index of hepatocellular damage in epileptic patients.
    Acta neurologica Scandinavica, 1994, Volume: 89, Issue:4

    Topics: Adult; Alkaline Phosphatase; Anticonvulsants; Aspartate Aminotransferases; Carbamazepine; Chemical a

1994
Neurological side effects related to valproate after neurosurgery.
    Acta neurochirurgica, 1994, Volume: 127, Issue:3-4

    Topics: Acidosis; Adult; Aged; Akathisia, Drug-Induced; Anesthesia Recovery Period; Craniotomy; Epilepsy, Ge

1994
Disabling tremor after lamotrigine with sodium valproate.
    Lancet (London, England), 1993, Jul-17, Volume: 342, Issue:8864

    Topics: Anticonvulsants; Drug Interactions; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Lamotrigi

1993
[The antiepileptic effects of the combined action of the new 1,4-dihydropyridine derivative glutapyrone with sodium valproate and phenobarbital].
    Biulleten' eksperimental'noi biologii i meditsiny, 1993, Volume: 116, Issue:12

    Topics: 4-Aminopyridine; Animals; Anticonvulsants; Dihydropyridines; Drug Evaluation, Preclinical; Drug Ther

1993
[Absence seizures in adulthood: four cases].
    Neurologia (Barcelona, Spain), 1994, Volume: 9, Issue:1

    Topics: Adult; Age Factors; Age of Onset; Drug Therapy, Combination; Electroencephalography; Epilepsy, Absen

1994
Differential effects of first antiepileptic drug application on cognition in lesional and non-lesional patients with epilepsy.
    Seizure, 1993, Volume: 2, Issue:2

    Topics: Attention; Brain Damage, Chronic; Carbamazepine; Cognition Disorders; Electroencephalography; Epilep

1993
A new chronic model of spontaneous nonconvulsive generalized seizures.
    The Japanese journal of psychiatry and neurology, 1993, Volume: 47, Issue:2

    Topics: 4-Butyrolactone; Animals; Cerebral Cortex; Corpus Callosum; Electroencephalography; Epilepsy, Absenc

1993
Myoclonus and seizures in a patient with parkinsonism: induction by levodopa and its confirmation on SEPs.
    The Japanese journal of psychiatry and neurology, 1993, Volume: 47, Issue:3

    Topics: Aged; Electroencephalography; Electromyography; Epilepsies, Myoclonic; Epilepsy, Generalized; Evoked

1993
Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    The New England journal of medicine, 1993, Nov-04, Volume: 329, Issue:19

    Topics: Adolescent; Adult; Analysis of Variance; Carbamazepine; Cross-Sectional Studies; Epilepsies, Partial

1993
Serum carnitine levels in ambulatory epilepsy outpatients.
    Seizure, 1996, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Ambulatory Care; Anticonvulsants; Carnitine; Drug Therapy, Combination; Epilepsie

1996
[Epileptic seizures during sleep].
    Revista de neurologia, 1996, Volume: 24, Issue:134

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Brain; Carbamazepine; Electroencephalography; Epilepsy, Ge

1996
Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p.
    The International journal of neuroscience, 1996, Volume: 87, Issue:3-4

    Topics: Adult; Anticonvulsants; Brain; Carbamazepine; Chromosome Aberrations; Chromosome Disorders; Chromoso

1996
Nonconvulsive status epilepticus with generalized 'fast activity'.
    Seizure, 1997, Volume: 6, Issue:1

    Topics: Alpha Rhythm; Anticonvulsants; Cerebral Cortex; Diagnosis, Differential; Drug Therapy, Combination;

1997
Hyperkinesias in a prepubertal boy with autistic disorder treated with haloperidol and valproic acid.
    Psychological reports, 1997, Volume: 80, Issue:1

    Topics: Anti-Dyskinesia Agents; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Autistic Dis

1997
Effects of valproate, phenytoin, and MK-801 in a novel model of epileptogenesis.
    Epilepsia, 1997, Volume: 38, Issue:6

    Topics: Animals; Anticonvulsants; Behavior, Animal; Brain Stem; Disease Models, Animal; Dizocilpine Maleate;

1997
[The efficacy of the valproic acid-ethosuximide combination in the continuous slow point wave syndrome during sleep].
    Neurologia (Barcelona, Spain), 1997, Volume: 12, Issue:8

    Topics: Anticonvulsants; Brain; Child; Electroencephalography; Epilepsy, Generalized; Ethosuximide; Female;

1997
[Lamotrigine (Lamictal)].
    Revue medicale de Liege, 1997, Volume: 52, Issue:11

    Topics: Anticonvulsants; Brain; Child; Child, Preschool; Drug Combinations; Drug Eruptions; Epilepsies, Part

1997
[Side effects of anticonvulsants in the treatment of idiopathic generalized epilepsy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1997, Volume: 97, Issue:7

    Topics: Adolescent; Adult; Anticonvulsants; Barbiturates; Central Nervous System; Child; Child, Preschool; D

1997
Treatment of the epileptic patient in the dental office.
    The New York state dental journal, 1998, Volume: 64, Issue:2

    Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Child; Dental Care for Chronically Ill; Emergencies; Ep

1998
Central benzodiazepine/gamma-aminobutyric acid A receptors in idiopathic generalized epilepsy: an [11C]flumazenil positron emission tomography study.
    Epilepsia, 1997, Volume: 38, Issue:10

    Topics: Adult; Analysis of Variance; Brain; Carbon Radioisotopes; Cerebellum; Cerebral Cortex; Epilepsy, Gen

1997
Idiopathic generalised epilepsy in adults manifested by phantom absences, generalised tonic-clonic seizures, and frequent absence status.
    Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 65, Issue:2

    Topics: Adult; Electroencephalography; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Evo

1998
Worsening seizures after surgery for focal epilepsy due to emergence of primary generalized epilepsy.
    Neurology, 1998, Volume: 51, Issue:4

    Topics: Adolescent; Anticonvulsants; Disease Progression; Electroencephalography; Epilepsies, Partial; Epile

1998
Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate.
    Seizure, 1999, Volume: 8, Issue:4

    Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Epilepsy, Generalized; Female; Folic Acid; Huma

1999
Primary ciliary dyskinesia syndrome and primary generalised epilepsy.
    Scottish medical journal, 1999, Volume: 44, Issue:3

    Topics: Adult; Anticonvulsants; Child; Child, Preschool; Ciliary Motility Disorders; Electroencephalography;

1999
Platelet count and function in children receiving sodium valproate.
    Pediatric neurology, 1999, Volume: 21, Issue:3

    Topics: Adenosine Triphosphate; Anticonvulsants; Blood Platelets; Case-Control Studies; Child; Child, Presch

1999
Clozapine-induced stuttering: epileptic brain activity?
    The American journal of psychiatry, 1999, Volume: 156, Issue:10

    Topics: Anticonvulsants; Antipsychotic Agents; Brain; Clozapine; Dose-Response Relationship, Drug; Electroen

1999
Fatal pulmonary hemorrhage during high-dose valproate monotherapy.
    Chest, 2000, Volume: 117, Issue:2

    Topics: Adult; Anticonvulsants; Epilepsy, Generalized; Fatal Outcome; Female; Hemorrhage; Humans; Lung Disea

2000
[Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy].
    Der Nervenarzt, 2000, Volume: 71, Issue:5

    Topics: Adult; Antimanic Agents; Ataxia; Bipolar Disorder; Brain Diseases, Metabolic; Dyskinesias; Epilepsy,

2000
Migraine-associated seizure: a case of reversible MRI abnormalities and persistent nondominant hemisphere syndrome.
    Headache, 2000, Volume: 40, Issue:6

    Topics: Anticonvulsants; Brain; Epilepsy, Generalized; Female; Humans; Magnetic Resonance Imaging; Middle Ag

2000
Exceptionally long absence status: multifactorial etiology, drug interactions and complications.
    Epileptic disorders : international epilepsy journal with videotape, 1999, Volume: 1, Issue:4

    Topics: Aged; Anticonvulsants; Brain Ischemia; Dementia, Vascular; Drug Interactions; Epilepsy, Generalized;

1999
Nonconvulsive status epilepticus causing acute confusion.
    Age and ageing, 2000, Volume: 29, Issue:4

    Topics: Acute Disease; Aged; Anticonvulsants; Confusion; Diazepam; Epilepsy, Generalized; Fatal Outcome; Fem

2000
Idiopathic generalized epilepsy presenting with hemiconvulsive seizures.
    Epilepsia, 2000, Volume: 41, Issue:12

    Topics: Adolescent; Anticonvulsants; Child; Comorbidity; Electroencephalography; Epilepsy, Frontal Lobe; Epi

2000
A case of pharmacokinetic interference in comedication of clozapine and valproic acid.
    Pharmacopsychiatry, 2000, Volume: 33, Issue:6

    Topics: Adult; Anticonvulsants; Clozapine; Drug Interactions; Drug Therapy, Combination; Epilepsy, Generaliz

2000
Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy.
    Neurology, 2001, Jan-09, Volume: 56, Issue:1

    Topics: Adolescent; Adult; Androstenedione; Anticonvulsants; Carbamazepine; Dehydroepiandrosterone Sulfate;

2001
Absence epilepsy with fast rhythmic discharges during sleep: an intermediary form of generalized epilepsy?
    Epilepsia, 2001, Volume: 42, Issue:3

    Topics: Adult; Age of Onset; Anticonvulsants; Cerebral Cortex; Child; Child, Preschool; Diagnosis, Different

2001
Pediatric migraine prophylaxis with divalproex.
    Journal of child neurology, 2001, Volume: 16, Issue:10

    Topics: Adolescent; Child; Epilepsy, Generalized; Epilepsy, Rolandic; Female; Humans; Male; Mental Disorders

2001
'Foetal valproate syndrome and autism: additional evidence of an association'.
    Developmental medicine and child neurology, 2001, Volume: 43, Issue:12

    Topics: Abnormalities, Drug-Induced; Autistic Disorder; Child; Epilepsy, Generalized; Female; Humans; Male;

2001
[Metopic craniosynostosis, probable effect of intrauterine exposure to maternal valproate treatment].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2001, Volume: 8, Issue:12

    Topics: Abnormalities, Drug-Induced; Craniosynostoses; Diseases in Twins; Epilepsy, Generalized; Female; Hum

2001
Smoldering myeloma associated with zonisamide treatment.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:2

    Topics: Adult; Agammaglobulinemia; Anticonvulsants; Epilepsy, Generalized; Humans; Immunoglobulin lambda-Cha

2002
Valproate-associated stomatitis.
    Journal of child neurology, 2002, Volume: 17, Issue:3

    Topics: Anticonvulsants; Child, Preschool; Electroencephalography; Epilepsy, Generalized; Female; Humans; St

2002
[The antiepileptic effects of sodium valproate and the calcium antagonist riodipine when used jointly in a model of generalized korazol-induced epileptic activity].
    Biulleten' eksperimental'noi biologii i meditsiny, 1992, Volume: 114, Issue:10

    Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Ev

1992
[A case of Klippel-Trenaunay-Weber syndrome accompanied by congenital hydrocephalus and micropolygyria].
    No to hattatsu = Brain and development, 1992, Volume: 24, Issue:4

    Topics: Brain; Electroencephalography; Epilepsy, Generalized; Humans; Hydrocephalus; Infant, Newborn; Klippe

1992
Therapeutic drug monitoring improves seizure control and reduces anticonvulsant side-effects in patients with refractory epilepsy.
    Seizure, 1992, Volume: 1, Issue:4

    Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Monitoring; Electroencephalog

1992
Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma.
    Acta neurologica Scandinavica, 1992, Volume: 86, Issue:3

    Topics: Adult; Amino Acid Metabolism, Inborn Errors; Ammonia; Atrophy; Carbamoyl-Phosphate Synthase (Ammonia

1992
Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics.
    Biological psychiatry, 1992, Mar-15, Volume: 31, Issue:6

    Topics: Adult; Anticonvulsants; Carbamazepine; Copper; Drug Therapy, Combination; Epilepsy, Generalized; Fem

1992